{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:06:42Z","timestamp":1789528002693,"version":"build-2803163510"},"reference-count":263,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atopic dermatitis (AD) is a common chronic inflammatory skin disorder with a continuously increasing global incidence. Current therapeutic options are often associated with adverse effects. In recent years, natural products have attracted considerable attention due to their anti-inflammatory and antioxidant properties, which can effectively alleviate the symptoms of AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study provides a comprehensive review of the research progress on the use of natural ingredients for the treatment of AD both domestically and internationally, with an emphasis on their efficacy and advantages in the context of AD pathogenesis. The aim is to offer a reference for the development of herbal ingredients as safer complementary or alternative therapeutic agents for AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was performed using key terms such as \u201catopic dermatitis\u201d, \u201cnatural products\u201d, \u201canti-inflammatory\u201d, \u201cskin barrier dysfunction\u201d, \u201canti-pruritic\u201d, \u201cantimicrobial\u201d, \u201cantioxidant\u201d, \u201cgut microbiota\u201d, and their combinations in databases including CNKI, PubMed, and Google Scholar. We systematically evaluated the pathogenesis and therapeutic mechanisms of AD, with a particular emphasis on in vivo studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Research has demonstrated that natural ingredients exhibit multifaceted advantages in the treatment of AD, including anti-inflammatory effects, skin barrier repair, anti-pruritic activity, modulation of the skin microbiota, alleviation of oxidative stress, and regulation of gut microbiota.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We discuss and analyze various bioactive natural ingredients capable of modulating cytokines and signaling pathways, while also identifying their major translational limitations, such as standardization and safety issues. This review provides a mechanistic and evidence-based reference for developing natural products as safe, adjunctive therapies for AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01497-8","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:42:05Z","timestamp":1789526525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The potential effects, mechanisms and translational perspectives of natural products in the treatment of atopic dermatitis"],"prefix":"10.1186","volume":"21","author":[{"given":"Changyu","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5756-0337","authenticated-orcid":false,"given":"Tianyang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"1497_CR1","doi-asserted-by":"publisher","unstructured":"Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251\u20131258.e23. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.009","DOI":"10.1016\/j.jaci.2009.10.009"},{"key":"1497_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/cea.13784","volume":"51","author":"S de Lusignan","year":"2021","unstructured":"de Lusignan S, Alexander H, Broderick C, Dennis J, McGovern A, Feeney C, et al. The epidemiology of eczema in children and adults in England: a population-based study using primary care data. Clin Exp Allergy. 2021;51:471\u201382. https:\/\/doi.org\/10.1111\/cea.13784.","journal-title":"Clin Exp Allergy"},{"key":"1497_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjd.19580","volume":"184","author":"MR Laughter","year":"2021","unstructured":"Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990\u20132017. Br J Dermatol. 2021;184:304\u20139. https:\/\/doi.org\/10.1111\/bjd.19580.","journal-title":"Br J Dermatol"},{"key":"1497_CR4","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.3390\/ijms21186484","volume":"21","author":"B Nedoszytko","year":"2020","unstructured":"Nedoszytko B, Reszka E, Gutowska-Owsiak D, Trzeciak M, Lange M, Jarczak J, et al. Genetic and epigenetic aspects of atopic dermatitis. Int J Mol Sci. 2020;21:6484. https:\/\/doi.org\/10.3390\/ijms21186484.","journal-title":"Int J Mol Sci"},{"key":"1497_CR5","doi-asserted-by":"publisher","DOI":"10.5070\/D3216027812","volume":"21","author":"C Karimkhani","year":"2015","unstructured":"Karimkhani C, Silverberg JI, Dellavalle RP. Defining intrinsic vs. extrinsic atopic dermatitis. Dermatol Online J. 2015;21:13030\/qt14p8p404.","journal-title":"Dermatol Online J"},{"key":"1497_CR6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jaip.2017.10.005","volume":"6","author":"JI Silverberg","year":"2018","unstructured":"Silverberg JI, Vakharia PP, Chopra R, Sacotte R, Patel N, Immaneni S, et al. Phenotypical differences of childhood- and adult-onset atopic dermatitis. J Allergy Clin Immunol Pract. 2018;6:1306\u201312. https:\/\/doi.org\/10.1016\/j.jaip.2017.10.005.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1497_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/exd.13514","volume":"27","author":"BP Kaufman","year":"2018","unstructured":"Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups-variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27:340\u201357. https:\/\/doi.org\/10.1111\/exd.13514.","journal-title":"Exp Dermatol"},{"key":"1497_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eujim.2017.03.008","volume":"12","author":"JH Jun","year":"2017","unstructured":"Jun JH, Lee JA, Roh S-S, Choi J, Choi TY, Kim B, et al. Nourishing yin method using herbal medicine for skin disease: a systematic review and meta-analysis. Eur J Integr Med. 2017;12:1\u201311. https:\/\/doi.org\/10.1016\/j.eujim.2017.03.008.","journal-title":"Eur J Integr Med"},{"key":"1497_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11655-015-2438-1","volume":"25","author":"M-Q Man","year":"2019","unstructured":"Man M-Q, Hu L-Z, Elias PM. Herbal medicines prevent the development of atopic dermatitis by multiple mechanisms. Chin J Integr Med. 2019;25:151\u201360. https:\/\/doi.org\/10.1007\/s11655-015-2438-1.","journal-title":"Chin J Integr Med"},{"key":"1497_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jaci.2014.07.060","volume":"134","author":"K Horimukai","year":"2014","unstructured":"Horimukai K, Morita K, Narita M, Kondo M, Kitazawa H, Nozaki M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134:824-830.e6. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.060.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","volume":"134","author":"EL Simpson","year":"2014","unstructured":"Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WHI, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134:818\u201323. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.005.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55393","volume":"16","author":"TD Hernandez","year":"2024","unstructured":"Hernandez TD, Aleman SJ, Bao-Loc-Trung M, Forte MV, Brandt W, Armstrong C, et al. Advancing treatment in atopic dermatitis: a comprehensive review of clinical efficacy, safety, and comparative insights into corticosteroids, calcineurin inhibitors, and phosphodiesterase-4 inhibitors as topical therapies. Cureus. 2024;16:e55393. https:\/\/doi.org\/10.7759\/cureus.55393.","journal-title":"Cureus"},{"key":"1497_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/pde.15172","volume":"40","author":"P Anand","year":"2023","unstructured":"Anand P, Schneeweiss S, Mostaghimi A, Schneeweiss MC. Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis. Pediatr Dermatol. 2023;40:132\u20134. https:\/\/doi.org\/10.1111\/pde.15172.","journal-title":"Pediatr Dermatol"},{"key":"1497_CR14","first-page":"22","volume":"16","author":"AM Snyder","year":"2023","unstructured":"Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, et al. Atopic dermatitis: a qualitative study on the burdens of living with itchiness. J Clin Aesthet Dermatol. 2023;16:22\u20135.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1497_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2133.2007.07941.x","volume":"157","author":"KLE Hon","year":"2007","unstructured":"Hon KLE, Leung TF, Ng PC, Lam MCA, Kam WYC, Wong KY, et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2007;157:357\u201363. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07941.x.","journal-title":"Br J Dermatol"},{"key":"1497_CR16","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.3390\/cells11233930","volume":"11","author":"CS Moniaga","year":"2022","unstructured":"Moniaga CS, Tominaga M, Takamori K. An altered skin and gut microbiota are involved in the modulation of itch in atopic dermatitis. Cells. 2022;11:3930. https:\/\/doi.org\/10.3390\/cells11233930.","journal-title":"Cells"},{"key":"1497_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75:494-503.e6. https:\/\/doi.org\/10.1016\/j.jaad.2016.05.046.","journal-title":"J Am Acad Dermatol"},{"key":"1497_CR18","doi-asserted-by":"publisher","unstructured":"Gooderham M, Kircik L, Zirwas M, Lee M, Kempers S, Draelos Z, et al. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study. J Drugs Dermatol. 2023;22:139\u201347. https:\/\/doi.org\/10.36849\/JDD.7295","DOI":"10.36849\/JDD.7295"},{"key":"1497_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2021.10.027","volume":"86","author":"H Saeki","year":"2022","unstructured":"Saeki H, Ito K, Yokota D, Tsubouchi H. Difamilast ointment in adult patients with atopic dermatitis: a phase 3 randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol. 2022;86:607\u201314. https:\/\/doi.org\/10.1016\/j.jaad.2021.10.027.","journal-title":"J Am Acad Dermatol"},{"key":"1497_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2022.100679","volume":"96","author":"A Mart\u00edn-Santiago","year":"2022","unstructured":"Mart\u00edn-Santiago A, Puig S, Arumi D, Rebollo Laserna FJ. Safety Profile and Tolerability of topical phosphodiesterase 4 inhibitors for the treatment of atopic dermatitis: a systematic review and meta-analysis. Curr Ther Res. 2022;96:100679. https:\/\/doi.org\/10.1016\/j.curtheres.2022.100679.","journal-title":"Curr Ther Res"},{"key":"1497_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.2517","author":"CM Boesjes","year":"2024","unstructured":"Boesjes CM, Kamphuis E, de Graaf M, Spekhorst LS, Haeck I, van der Gang LF, et al. Long-term effectiveness and reasons for discontinuation of dupilumab in patients with atopic dermatitis. JAMA Dermatol. 2024. https:\/\/doi.org\/10.1001\/jamadermatol.2024.2517.","journal-title":"JAMA Dermatol"},{"key":"1497_CR22","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1111\/jdv.20264","volume":"39","author":"J Dupuis","year":"2025","unstructured":"Dupuis J, Tauber M, Mahe E, Jachiet M, Soria A, Tetart F, et al. Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity. J Eur Acad Dermatol Venereol. 2025;39:e174\u20138. https:\/\/doi.org\/10.1111\/jdv.20264.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1497_CR23","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.bmcl.2019.04.008","volume":"29","author":"M Zak","year":"2019","unstructured":"Zak M, Hanan EJ, Lupardus P, Brown DG, Robinson C, Siu M, et al. Discovery of a class of highly potent Janus Kinase 1\/2 (JAK1\/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. Bioorg Med Chem Lett. 2019;29:1522\u201331. https:\/\/doi.org\/10.1016\/j.bmcl.2019.04.008.","journal-title":"Bioorg Med Chem Lett"},{"key":"1497_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1159\/000518541","volume":"238","author":"C Li","year":"2022","unstructured":"Li C, Sun X, Zhao K, Meng F, Li L, Mu Z, et al. Efficacy and safety of Janus kinase inhibitors for the treatment of atopic dermatitis: a systematic review and meta-analysis. Dermatology (Basel). 2022;238:725\u201335. https:\/\/doi.org\/10.1159\/000518541.","journal-title":"Dermatology (Basel)"},{"key":"1497_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.23736\/S2784-8671.24.07749-1","volume":"159","author":"DA Pires","year":"2024","unstructured":"Pires DA, Rosa G, Cruz MJ, Azevedo F, Mota A. Concurrent therapy with dupilumab and infliximab for atopic dermatitis and Crohn\u2019s disease. Ital J Dermatol Venerol. 2024;159:473\u20134. https:\/\/doi.org\/10.23736\/S2784-8671.24.07749-1.","journal-title":"Ital J Dermatol Venerol"},{"key":"1497_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/205873920601900125","volume":"19","author":"N Cassano","year":"2006","unstructured":"Cassano N, Loconsole F, Coviello C, Vena GA. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int J Immunopathol Pharmacol. 2006;19:237\u201340.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1497_CR27","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/j.anai.2022.08.826","volume":"129","author":"E Boateng","year":"2022","unstructured":"Boateng E, Plager J, Kahwash B. Severe atopic dermatitis improved with omalizumab treatment of cholinergic urticaria. Ann Allergy Asthma Immunol. 2022;129:S114. https:\/\/doi.org\/10.1016\/j.anai.2022.08.826.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1497_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12817","volume":"32","author":"E Thomaidou","year":"2019","unstructured":"Thomaidou E, Ramot Y. Injection site reactions with the use of biological agents. Dermatol Ther. 2019;32:e12817. https:\/\/doi.org\/10.1111\/dth.12817.","journal-title":"Dermatol Ther"},{"key":"1497_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/jdv.70080","volume":"40","author":"M Augustin","year":"2026","unstructured":"Augustin M, Tauber M, Sidbury R, Silverberg JI, Papp KA, Tha\u00e7i D, et al. Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study. J Eur Acad Dermatol Venereol. 2026;40:841\u201355. https:\/\/doi.org\/10.1111\/jdv.70080.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1497_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825312","volume":"13","author":"J Liang","year":"2022","unstructured":"Liang J, Hu F, Dan M, Sang Y, Abulikemu K, Wang Q, et al. Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial. Front Immunol. 2022;13:825312. https:\/\/doi.org\/10.3389\/fimmu.2022.825312.","journal-title":"Front Immunol"},{"key":"1497_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/bjd\/ljad022","volume":"188","author":"A Blauvelt","year":"2023","unstructured":"Blauvelt A, Thyssen JP, Guttman-Yassky E, Bieber T, Serra-Baldrich E, Simpson E, et al. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials. Br J Dermatol. 2023;188:740\u20138. https:\/\/doi.org\/10.1093\/bjd\/ljad022.","journal-title":"Br J Dermatol"},{"key":"1497_CR32","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/jdv.18429","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022;36:1904\u201326. https:\/\/doi.org\/10.1111\/jdv.18429.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1497_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1769109","volume":"17","author":"Y Jiang","year":"2026","unstructured":"Jiang Y, Sun X, Li Y. Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database. Front Immunol. 2026;17:1769109. https:\/\/doi.org\/10.3389\/fimmu.2026.1769109.","journal-title":"Front Immunol"},{"key":"1497_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2026.2648209","author":"M Chen","year":"2026","unstructured":"Chen M, Ke C, Huang Y. Comprehensive pharmacovigilance analysis of lebrikizumab: a real-world safety assessment based on the FDA Adverse Event Reporting System (FAERS) database. Immunopharmacol Immunotoxicol. 2026. https:\/\/doi.org\/10.1080\/08923973.2026.2648209.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1497_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1068260","author":"I-H Huang","year":"2022","unstructured":"Huang I-H, Chung W-H, Wu P-C, Chen C-B. JAK\u2013STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1068260.","journal-title":"Front Immunol"},{"key":"1497_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2500\/aap.2025.46.240113","volume":"46","author":"M Wang","year":"2025","unstructured":"Wang M, Gao X, Zhang L. Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: a systematic review and meta-analysis. Allergy Asthma Proc. 2025;46:88\u201397. https:\/\/doi.org\/10.2500\/aap.2025.46.240113.","journal-title":"Allergy Asthma Proc"},{"key":"1497_CR37","doi-asserted-by":"publisher","unstructured":"Chen M, Huang Y, Jiang S, Ke C. Safety assessment of KRAS (G12C) inhibitors based on the FDA Adverse Event Reporting System (FAERS) database: A real-world pharmacovigilance study. Lung Cancer. https:\/\/doi.org\/10.1016\/j.lungcan.2024.107966","DOI":"10.1016\/j.lungcan.2024.107966"},{"key":"1497_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20682","author":"C Droitcourt","year":"2025","unstructured":"Droitcourt C, Kerbrat S, Staumont-Salle D, Lescoat A, Oger E, Scailteux L. Venous thromboembolic events in patients treated with Janus kinase inhibitors for atopic dermatitis. Acad Dermatol Venereol. 2025. https:\/\/doi.org\/10.1111\/jdv.20682.","journal-title":"Acad Dermatol Venereol"},{"key":"1497_CR39","doi-asserted-by":"publisher","first-page":"107602962514132","DOI":"10.1177\/10760296251413253","volume":"32","author":"Z Chen","year":"2026","unstructured":"Chen Z, Wang S, Wang Y. Association of venous thromboembolism risk with atopic dermatitis and janus kinase inhibitors treatment: a mendelian randomization study. Clin Appl Thromb Hemost. 2026;32:10760296251413252. https:\/\/doi.org\/10.1177\/10760296251413253.","journal-title":"Clin Appl Thromb Hemost"},{"key":"1497_CR40","doi-asserted-by":"publisher","unstructured":"Manzar D, Nair N, Suntres E, Rodrigues M, Alghanemi L, Abu-Hilal M. Systematic review and network meta-analysis of the risk of malignancy with biologic therapies and selective Janus kinase-1 inhibitors in atopic dermatitis. PDIA. 2024;41:270\u20135. https:\/\/doi.org\/10.5114\/ada.2024.141125","DOI":"10.5114\/ada.2024.141125"},{"key":"1497_CR41","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1056\/NEJMc2202778","volume":"386","author":"A Ozdede","year":"2022","unstructured":"Ozdede A, Yaz\u0131c\u0131 H. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med. 2022;386:1766. https:\/\/doi.org\/10.1056\/NEJMc2202778.","journal-title":"N Engl J Med"},{"key":"1497_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/derm.2024.0106","volume":"36","author":"H Liu","year":"2025","unstructured":"Liu H. Effect of skin barrier on atopic dermatitis. Dermatitis. 2025;36:37\u201345. https:\/\/doi.org\/10.1089\/derm.2024.0106.","journal-title":"Dermatitis"},{"key":"1497_CR43","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/gb-2012-13-11-r101","volume":"13","author":"PLJM Zeeuwen","year":"2012","unstructured":"Zeeuwen PLJM, Boekhorst J, van den Bogaard EH, de Koning HD, van de Kerkhof PMC, Saulnier DM, et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 2012;13:R101. https:\/\/doi.org\/10.1186\/gb-2012-13-11-r101.","journal-title":"Genome Biol"},{"key":"1497_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.molmed.2019.04.001","volume":"25","author":"N Bhattacharya","year":"2019","unstructured":"Bhattacharya N, Sato WJ, Kelly A, Ganguli-Indra G, Indra AK. Epidermal lipids: key mediators of atopic dermatitis pathogenesis. Trends Mol Med. 2019;25:551\u201362. https:\/\/doi.org\/10.1016\/j.molmed.2019.04.001.","journal-title":"Trends Mol Med"},{"key":"1497_CR45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","volume":"61","author":"H Li","year":"2021","unstructured":"Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol. 2021;61:324\u201338. https:\/\/doi.org\/10.1007\/s12016-021-08880-3.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1497_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/08923973.2021.1889583","volume":"43","author":"DS Mandlik","year":"2021","unstructured":"Mandlik DS, Mandlik SK. Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies. Immunopharmacol Immunotoxicol. 2021;43:105\u201325. https:\/\/doi.org\/10.1080\/08923973.2021.1889583.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1497_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.det.2017.02.006","volume":"35","author":"K Malik","year":"2017","unstructured":"Malik K, Heitmiller KD, Czarnowicki T. An update on the pathophysiology of atopic dermatitis. Dermatol Clin. 2017;35:317\u201326. https:\/\/doi.org\/10.1016\/j.det.2017.02.006.","journal-title":"Dermatol Clin"},{"key":"1497_CR48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","volume":"126","author":"BE Kim","year":"2008","unstructured":"Kim BE, Leung DYM, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008;126:332\u20137. https:\/\/doi.org\/10.1016\/j.clim.2007.11.006.","journal-title":"Clin Immunol"},{"key":"1497_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116765","volume":"176","author":"K-S Shim","year":"2024","unstructured":"Shim K-S, Song H-K, Park M, Kim HJ, Jang S, Kim T, et al. Reynoutria japonica consisted of emodin-8-\u03b2-D-glucoside ameliorates Dermatophagoides farinae extract-induced atopic dermatitis-like skin inflammation in mice by inhibiting JAK\/STAT signaling. Biomed Pharmacother. 2024;176:116765. https:\/\/doi.org\/10.1016\/j.biopha.2024.116765.","journal-title":"Biomed Pharmacother"},{"key":"1497_CR50","doi-asserted-by":"publisher","first-page":"984","DOI":"10.4049\/jimmunol.179.2.984","volume":"179","author":"C Albanesi","year":"2007","unstructured":"Albanesi C, Fairchild HR, Madonna S, Scarponi C, De Pit\u00e0 O, Leung DYM, et al. IL-4 and IL-13 negatively regulate TNF-\u03b1- and IFN-\u03b3-induced \u03b2-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol. 2007;179:984\u201392. https:\/\/doi.org\/10.4049\/jimmunol.179.2.984.","journal-title":"J Immunol"},{"key":"1497_CR51","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1056\/NEJMoa021481","volume":"347","author":"PY Ong","year":"2002","unstructured":"Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151\u201360. https:\/\/doi.org\/10.1056\/NEJMoa021481.","journal-title":"N Engl J Med"},{"key":"1497_CR52","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/jid.2014.43","volume":"134","author":"AM Brauweiler","year":"2014","unstructured":"Brauweiler AM, Goleva E, Leung DYM. Th2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6). J Invest Dermatol. 2014;134:2114\u201321. https:\/\/doi.org\/10.1038\/jid.2014.43.","journal-title":"J Invest Dermatol"},{"key":"1497_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/jid.2008.259","volume":"129","author":"A De Benedetto","year":"2009","unstructured":"De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects. J Invest Dermatol. 2009;129:14\u201330. https:\/\/doi.org\/10.1038\/jid.2008.259.","journal-title":"J Invest Dermatol"},{"key":"1497_CR54","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","volume":"60","author":"JM Oldhoff","year":"2005","unstructured":"Oldhoff JM, Darsow U, Werfel T, Katzer K, Wulf A, Laifaoui J, et al. Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis. Allergy. 2005;60:693\u20136. https:\/\/doi.org\/10.1111\/j.1398-9995.2005.00791.x.","journal-title":"Allergy"},{"key":"1497_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/all.13239","volume":"73","author":"M Furue","year":"2018","unstructured":"Furue M, Yamamura K, Kido-Nakahara M, Nakahara T, Fukui Y. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis. Allergy. 2018;73:29\u201336. https:\/\/doi.org\/10.1111\/all.13239.","journal-title":"Allergy"},{"key":"1497_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006566","volume":"13","author":"P Kasparek","year":"2017","unstructured":"Kasparek P, Ileninova Z, Zbodakova O, Kanchev I, Benada O, Chalupsky K, et al. KLK5 and KLK7 ablation fully rescues lethality of netherton syndrome-like phenotype. PLoS Genet. 2017;13:e1006566. https:\/\/doi.org\/10.1371\/journal.pgen.1006566.","journal-title":"PLoS Genet"},{"key":"1497_CR57","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/jphp.12640","volume":"68","author":"SJ Lim","year":"2016","unstructured":"Lim SJ, Kim M, Randy A, Nam EJ, Nho CW. Effects of Hovenia dulcis Thunb. extract and methyl vanillate on atopic dermatitis-like skin lesions and TNF-\u03b1\/IFN-\u03b3-induced chemokines production in HaCaT cells. J Pharm Pharmacol. 2016;68:1465\u201379. https:\/\/doi.org\/10.1111\/jphp.12640.","journal-title":"J Pharm Pharmacol"},{"key":"1497_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7831291","volume":"2016","author":"H-S Lim","year":"2016","unstructured":"Lim H-S, Seo C-S, Jin S-E, Yoo S-R, Lee M-Y, Shin H-K, et al. Ma Huang Tang suppresses the production and expression of inflammatory chemokines via downregulating STAT1 phosphorylation in HaCaT keratinocytes. Evid Based Complement Alternat Med. 2016;2016:7831291. https:\/\/doi.org\/10.1155\/2016\/7831291.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1497_CR59","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jaci.2020.10.006","volume":"147","author":"P Marschall","year":"2021","unstructured":"Marschall P, Wei R, Segaud J, Yao W, Hener P, German BF, et al. Dual function of Langerhans cells in skin TSLP-promoted TFH differentiation in mouse atopic dermatitis. J Allergy Clin Immunol. 2021;147:1778\u201394. https:\/\/doi.org\/10.1016\/j.jaci.2020.10.006.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR60","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.biopha.2016.09.085","volume":"84","author":"E-J Choi","year":"2016","unstructured":"Choi E-J, Debnath T, Tang Y, Ryu Y-B, Moon S-H, Kim E-K. Topical application of Moringa oleifera leaf extract ameliorates experimentally induced atopic dermatitis by the regulation of Th1\/Th2\/Th17 balance. Biomed Pharmacother. 2016;84:870\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2016.09.085.","journal-title":"Biomed Pharmacother"},{"key":"1497_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/odi.12053","volume":"19","author":"K Yamada","year":"2013","unstructured":"Yamada K, Yamaguchi M, Asano M, Fujita S, Kobayashi R, Kasai K. Th17-cells in atopic dermatitis stimulate orthodontic root resorption. Oral Dis. 2013;19:683\u201393. https:\/\/doi.org\/10.1111\/odi.12053.","journal-title":"Oral Dis"},{"key":"1497_CR62","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","volume":"139","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Guttman-Yassky E, Leung DYM. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol. 2017;139:S65-76. https:\/\/doi.org\/10.1016\/j.jaci.2017.01.011.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR63","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/life14030339","volume":"14","author":"J-H Lee","year":"2024","unstructured":"Lee J-H, Im D-S. Magnolol reduces atopic dermatitis-like symptoms in BALB\/c mice. Life (Basel). 2024;14:339. https:\/\/doi.org\/10.3390\/life14030339.","journal-title":"Life (Basel)"},{"key":"1497_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/life14040494","volume":"14","author":"S-Y Han","year":"2024","unstructured":"Han S-Y, Im D-S. Evodiamine alleviates 2,4-dinitro-1-chloro-benzene-induced atopic dermatitis-like symptoms in BALB\/c mice. Life. 2024;14:494. https:\/\/doi.org\/10.3390\/life14040494.","journal-title":"Life"},{"key":"1497_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115162","volume":"291","author":"J-E Lee","year":"2022","unstructured":"Lee J-E, Choi Y-W, Im D-S. Inhibitory effect of \u03b1-cubebenoate on atopic dermatitis-like symptoms by regulating Th2\/Th1\/Th17 balance in vivo. J Ethnopharmacol. 2022;291:115162. https:\/\/doi.org\/10.1016\/j.jep.2022.115162.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR66","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1111\/jocd.15383","volume":"21","author":"D-D Hou","year":"2022","unstructured":"Hou D-D, Wang X-X, Li S-J, Wang D-C, Niu Y, Xu Z-R, et al. Glycyrrhizic acid suppresses atopic dermatitis-like symptoms by regulating the immune balance. J Cosmet Dermatol. 2022;21:7090\u20139. https:\/\/doi.org\/10.1111\/jocd.15383.","journal-title":"J Cosmet Dermatol"},{"key":"1497_CR67","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.2147\/DDDT.S387893","volume":"16","author":"L Tang","year":"2022","unstructured":"Tang L, Gao J, Li X, Cao X, Zhou B. Molecular mechanisms of luteolin against atopic dermatitis based on network pharmacology and in vivo experimental validation. DDDT. 2022;16:4205\u201321. https:\/\/doi.org\/10.2147\/DDDT.S387893.","journal-title":"DDDT"},{"key":"1497_CR68","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.3390\/nu13124387","volume":"13","author":"J Jegal","year":"2021","unstructured":"Jegal J, Kim T-Y, Park N-J, Jo B-G, Jo G-A, Choi H-S, et al. Inhibitory Effects of Luteolin 7-Methyl Ether Isolated from Wikstroemia ganpi on Tnf-A\/Ifn-\u0393 Mixture-Induced Inflammation in Human Keratinocyte. Nutrients. 2021;13:4387. https:\/\/doi.org\/10.3390\/nu13124387.","journal-title":"Nutrients"},{"key":"1497_CR69","doi-asserted-by":"publisher","first-page":"12383","DOI":"10.1039\/D2FO02518C","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Qu L, Sun Y, Lin Y, Zeng J, He L, et al. Daphnetin contributes to allergen-induced Th2 cytokine expression and type 2-immune responses in atopic dermatitis and asthma. Food Funct. 2022;13:12383\u201399. https:\/\/doi.org\/10.1039\/D2FO02518C.","journal-title":"Food Funct"},{"key":"1497_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105538","volume":"119","author":"L Wang","year":"2022","unstructured":"Wang L, Xian Y-F, Loo SKF, Ip SP, Yang W, Chan WY, et al. Baicalin ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice through modulating skin barrier function, gut microbiota and JAK\/STAT pathway. Bioorg Chem. 2022;119:105538. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105538.","journal-title":"Bioorg Chem"},{"key":"1497_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s13273-024-00476-0","author":"C Xie","year":"2024","unstructured":"Xie C, Hu M, Niu B. Mangiferin can alleviate atopic dermatitis-like responses in mice and HaCaT cells. Mol Cell Toxicol. 2024. https:\/\/doi.org\/10.1007\/s13273-024-00476-0.","journal-title":"Mol Cell Toxicol"},{"issue":"25","key":"1497_CR72","doi-asserted-by":"publisher","first-page":"00044","DOI":"10.1016\/j.joim.2025.03.005","volume":"S2095\u20134964","author":"H Zhao","year":"2025","unstructured":"Zhao H, Ma X, Wang H, Ding X-J, Kuai L, Song J-K, et al. Prim-O-glucosylcimifugin mitigates atopic dermatitis by inhibiting Th2 differentiation through LCK phosphorylation modulation. J Integr Med. 2025;S2095\u20134964(25):00044\u20135. https:\/\/doi.org\/10.1016\/j.joim.2025.03.005.","journal-title":"J Integr Med"},{"key":"1497_CR73","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1515\/med-2019-0099","volume":"14","author":"M Wang","year":"2019","unstructured":"Wang M, Ma J. Effect of NGR1 on the atopic dermatitis model and its mechanisms. Open Med (Wars). 2019;14:847\u201353. https:\/\/doi.org\/10.1515\/med-2019-0099.","journal-title":"Open Med (Wars)"},{"key":"1497_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118439","volume":"333","author":"Z Huang","year":"2024","unstructured":"Huang Z, Fan B, Mao W, Kuai L, Feng J, Wang Y, et al. Topical application of Artemisia annua L. essential oil ameliorates 2,4-dintrochlorobenzene-induced atopic dermatitis in mice. J Ethnopharmacol. 2024;333:118439. https:\/\/doi.org\/10.1016\/j.jep.2024.118439.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115727","volume":"168","author":"J Li","year":"2023","unstructured":"Li J, Duan J, Wang Y, Zhou P, Wang X, Xia N, et al. The JAK\/STAT\/NF-\u03baB signaling pathway can be regulated by rosemary essential oil, thereby providing a potential treatment for DNCB-induced in mice. Biomed Pharmacother. 2023;168:115727. https:\/\/doi.org\/10.1016\/j.biopha.2023.115727.","journal-title":"Biomed Pharmacother"},{"key":"1497_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2023.105525","volume":"17","author":"J Duan","year":"2024","unstructured":"Duan J, Li J, Wang Y, Zhou P, Wang X, Xia N, et al. Therapeutic effects and mechanism of action of lavender essential oil on atopic dermatitis by modulating the STAT3\/ROR\u03b3t pathway. Arab J Chem. 2024;17:105525. https:\/\/doi.org\/10.1016\/j.arabjc.2023.105525.","journal-title":"Arab J Chem"},{"key":"1497_CR77","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/antiox10121941","volume":"10","author":"S-Y Kim","year":"2021","unstructured":"Kim S-Y, Han S-D, Kim M, Mony TJ, Lee E-S, Kim K-M, et al. Mentha arvensis Essential Oil Exerts Anti-Inflammatory in LPS-Stimulated Inflammatory Responses via Inhibition of ERK\/NF-\u03baB Signaling Pathway and Anti-Atopic Dermatitis-like Effects in 2,4-Dinitrochlorobezene-Induced BALB\/c Mice. Antioxidants. 2021;10:1941. https:\/\/doi.org\/10.3390\/antiox10121941.","journal-title":"Antioxidants"},{"key":"1497_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115195","volume":"292","author":"Y Gu","year":"2022","unstructured":"Gu Y, Wang X, Liu F, Zhang J, Zhang X, Liu J, et al. Total flavonoids of sea buckthorn (Hippophae rhamnoides L.) improve MC903-induced atopic dermatitis-like lesions. J Ethnopharmacol. 2022;292:115195. https:\/\/doi.org\/10.1016\/j.jep.2022.115195.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR79","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1002\/tox.24145","volume":"39","author":"W Wu","year":"2024","unstructured":"Wu W, Song L, Wang H, Feng L, Li Z, Li Y, et al. Supercritical CO2 fluid extract from Stellariae Radix ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by inhibit M1 macrophages polarization via AMPK activation. Environ Toxicol. 2024;39:3188\u201397. https:\/\/doi.org\/10.1002\/tox.24145.","journal-title":"Environ Toxicol"},{"key":"1497_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154318","volume":"104","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Song H-K, Park SH, Jang S, Park K-S, Song KH, et al. Terminalia chebula Retz. extract ameliorates the symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1\/3 and NF-\u0138B signaling in vitro. Phytomedicine. 2022;104:154318. https:\/\/doi.org\/10.1016\/j.phymed.2022.154318.","journal-title":"Phytomedicine"},{"key":"1497_CR81","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13020-022-00624-5","volume":"17","author":"G-Y Min","year":"2022","unstructured":"Min G-Y, Kim TI, Kim J-H, Cho W-K, Yang J-H, Ma J-Y. Inhibitory effect of Isatis tinctoria L. water extract on DNCB-induced atopic dermatitis in BALB\/c mice and HaCaT cells. Chin Med. 2022;17:66. https:\/\/doi.org\/10.1186\/s13020-022-00624-5.","journal-title":"Chin Med"},{"key":"1497_CR82","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4162\/nrp.2023.17.6.1056","volume":"17","author":"E-J Choi","year":"2023","unstructured":"Choi E-J, Choi JK. Extracts of Grifola frondosa inhibit the MAPK signaling pathways involved in keratinocyte inflammation and ameliorate atopic dermatitis. Nutr Res Pract. 2023;17:1056\u201369. https:\/\/doi.org\/10.4162\/nrp.2023.17.6.1056.","journal-title":"Nutr Res Pract"},{"key":"1497_CR83","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.phymed.2018.05.006","volume":"48","author":"K Cho","year":"2018","unstructured":"Cho K, Parveen A, Kang MC, Subedi L, Lee JH, Park SY, et al. Pyrus ussuriensis Maxim. leaves extract ameliorates DNCB-induced atopic dermatitis-like symptoms in NC\/Nga mice. Phytomedicine. 2018;48:76\u201383. https:\/\/doi.org\/10.1016\/j.phymed.2018.05.006.","journal-title":"Phytomedicine"},{"key":"1497_CR84","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/antiox12061267","volume":"12","author":"K-S Shim","year":"2023","unstructured":"Shim K-S, Park M, Yang W-K, Lee H, Kim S-H, Choo B-K, et al. Veronica persica ethanol extract ameliorates dinitrochlorobenzene-induced atopic dermatitis-like skin inflammation in mice, likely by inducing Nrf2\/HO-1 signaling. Antioxidants (Basel). 2023;12:1267. https:\/\/doi.org\/10.3390\/antiox12061267.","journal-title":"Antioxidants (Basel)"},{"key":"1497_CR85","doi-asserted-by":"publisher","first-page":"855","DOI":"10.4162\/nrp.2023.17.5.855","volume":"17","author":"HS Lee","year":"2023","unstructured":"Lee HS, Bae EY, Ly SY. Protective effect of Lycium barbarum leaf extracts on atopic dermatitis: in vitro and in vivo studies. Nutr Res Pract. 2023;17:855\u201369. https:\/\/doi.org\/10.4162\/nrp.2023.17.5.855.","journal-title":"Nutr Res Pract"},{"key":"1497_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109066","volume":"117","author":"J-H Park","year":"2019","unstructured":"Park J-H, Ahn E-K, Ko H-J, Lee JY, Hwang S-M, Ko S, et al. Korean red ginseng water extract alleviates atopic dermatitis-like inflammatory responses by negative regulation of mitogen-activated protein kinase signaling pathway in vivo. Biomed Pharmacother. 2019;117:109066. https:\/\/doi.org\/10.1016\/j.biopha.2019.109066.","journal-title":"Biomed Pharmacother"},{"key":"1497_CR87","doi-asserted-by":"publisher","unstructured":"Jayasinghe AMK, Kirindage KGIS, Kim S-H, Lee S, Jung K, Shim S-Y, et al. Protective effect of Curcuma longa L. leaves and pseudostems extract against 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis in BALB\/c mice. J Ethnopharmacol. 2025. https:\/\/doi.org\/10.1016\/j.jep.2024.119138","DOI":"10.1016\/j.jep.2024.119138"},{"key":"1497_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115160","volume":"291","author":"X Han","year":"2022","unstructured":"Han X, Chen Z, Yuan J, Wang G, Han X, Wu H, et al. Artemisia annua water extract attenuates DNCB-induced atopic dermatitis by restraining Th2 cell mediated inflammatory responses in BALB\/c mice. J Ethnopharmacol. 2022;291:115160. https:\/\/doi.org\/10.1016\/j.jep.2022.115160.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031455","volume":"23","author":"JK Hoober","year":"2022","unstructured":"Hoober JK, Eggink LL. The discovery and function of filaggrin. Int J Mol Sci. 2022;23:1455. https:\/\/doi.org\/10.3390\/ijms23031455.","journal-title":"Int J Mol Sci"},{"key":"1497_CR90","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/exd.13674","volume":"27","author":"I-Y Akemi","year":"2018","unstructured":"Akemi I-Y, Satomi I, Mari K. Molecular basis of the skin barrier structures revealed by electron microscopy. Exp Dermatol. 2018;27:841\u20136. https:\/\/doi.org\/10.1111\/exd.13674.","journal-title":"Exp Dermatol"},{"key":"1497_CR91","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2222.2010.03522.x","volume":"40","author":"GM O\u2019Regan","year":"2010","unstructured":"O\u2019Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010;40:965\u201372. https:\/\/doi.org\/10.1111\/j.1365-2222.2010.03522.x.","journal-title":"Clin Exp Allergy"},{"key":"1497_CR92","doi-asserted-by":"publisher","first-page":"148","DOI":"10.23736\/S0392-0488.16.05528-0","volume":"152","author":"I-Y Akemi","year":"2017","unstructured":"Akemi I-Y, Mari K, Masaru H. Desmosomes and corneodesmosomes and their relevance to genetic skin diseases. G Ital Dermatol Venereol. 2017;152:148\u201357. https:\/\/doi.org\/10.23736\/S0392-0488.16.05528-0.","journal-title":"G Ital Dermatol Venereol"},{"key":"1497_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2133.2003.05532.x","volume":"149","author":"S Kuenzli","year":"2003","unstructured":"Kuenzli S, Saurat J-H. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol. 2003;149:229\u201336. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05532.x.","journal-title":"Br J Dermatol"},{"key":"1497_CR94","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/35013000","volume":"405","author":"S Kersten","year":"2000","unstructured":"Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature. 2000;405:421\u20134. https:\/\/doi.org\/10.1038\/35013000.","journal-title":"Nature"},{"key":"1497_CR95","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0022-2275(20)42003-6","volume":"37","author":"K Schoonjans","year":"1996","unstructured":"Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res. 1996;37:907\u201325.","journal-title":"J Lipid Res"},{"key":"1497_CR96","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1172\/JCI119583","volume":"100","author":"K Hanley","year":"1997","unstructured":"Hanley K, Jiang Y, Crumrine D, Bass NM, Appel R, Elias PM, et al. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest. 1997;100:705\u201312. https:\/\/doi.org\/10.1172\/JCI119583.","journal-title":"J Clin Invest"},{"key":"1497_CR97","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1046\/j.1523-1747.1998.00439.x","volume":"111","author":"M Rivier","year":"1998","unstructured":"Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol. 1998;111:1116\u201321. https:\/\/doi.org\/10.1046\/j.1523-1747.1998.00439.x.","journal-title":"J Invest Dermatol"},{"key":"1497_CR98","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5021\/ad.2010.22.3.245","volume":"22","author":"PM Elias","year":"2010","unstructured":"Elias PM. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Ann Dermatol. 2010;22:245\u201354. https:\/\/doi.org\/10.5021\/ad.2010.22.3.245.","journal-title":"Ann Dermatol"},{"key":"1497_CR99","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3349\/ymj.2006.47.3.293","volume":"47","author":"SH Lee","year":"2006","unstructured":"Lee SH, Jeong SK, Ahn SK. An Update of the Defensive Barrier Function of Skin. Yonsei Med J. 2006;47:293\u2013306. https:\/\/doi.org\/10.3349\/ymj.2006.47.3.293.","journal-title":"Yonsei Med J"},{"key":"1497_CR100","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMra1011040","volume":"365","author":"AD Irvine","year":"2011","unstructured":"Irvine AD, McLean WHI, Leung DYM. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365:1315\u201327. https:\/\/doi.org\/10.1056\/NEJMra1011040.","journal-title":"N Engl J Med"},{"key":"1497_CR101","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jid.2023.02.021","volume":"143","author":"JPH Smits","year":"2023","unstructured":"Smits JPH, van den Brink NJM, Meesters LD, Hamdaoui H, Niehues H, Jansen PAM, et al. Investigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR\/Cas9 Editing of Human Keratinocytes. J Invest Dermatol. 2023;143:1520-1528.e5. https:\/\/doi.org\/10.1016\/j.jid.2023.02.021.","journal-title":"J Invest Dermatol"},{"key":"1497_CR102","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.ajpath.2011.01.053","volume":"178","author":"R Gruber","year":"2011","unstructured":"Gruber R, Elias PM, Crumrine D, Lin T-K, Brandner JM, Hachem J-P, et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol. 2011;178:2252\u201363. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.053.","journal-title":"Am J Pathol"},{"key":"1497_CR103","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1172\/JCI57416","volume":"122","author":"A Kubo","year":"2012","unstructured":"Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122:440\u20137. https:\/\/doi.org\/10.1172\/JCI57416.","journal-title":"J Clin Invest"},{"key":"1497_CR104","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/ptr.5138","volume":"28","author":"B Kim","year":"2014","unstructured":"Kim B, Choi Y-E, Kim H-S. Eruca sativa and its flavonoid components, quercetin and isorhamnetin, improve skin barrier function by activation of peroxisome proliferator-activated receptor (PPAR)-\u03b1 and suppression of inflammatory cytokines. Phytother Res. 2014;28:1359\u201366. https:\/\/doi.org\/10.1002\/ptr.5138.","journal-title":"Phytother Res"},{"key":"1497_CR105","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9370893","volume":"2016","author":"IJ Yang","year":"2016","unstructured":"Yang IJ, Lee D-U, Shin HM. Inhibitory effect of valencene on the development of atopic dermatitis-like skin lesions in NC\/Nga mice. Evid Based Complement Alternat Med. 2016;2016:9370893. https:\/\/doi.org\/10.1155\/2016\/9370893.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1497_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168431","volume":"22","author":"S-Y Min","year":"2021","unstructured":"Min S-Y, Park C-H, Yu H-W, Park Y-J. Anti-inflammatory and anti-allergic effects of saponarin and its impact on signaling pathways of RAW 264.7, RBL-2H3, and HaCaT cells. Int J Mol Sci. 2021;22:8431. https:\/\/doi.org\/10.3390\/ijms22168431.","journal-title":"Int J Mol Sci"},{"key":"1497_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158687","volume":"23","author":"N-J Park","year":"2022","unstructured":"Park N-J, Jo B-G, Bong S-K, Park S-A, Lee S, Kim YK, et al. Lobelia chinensis extract and its active compound, diosmetin, improve atopic dermatitis by reinforcing skin barrier function through SPINK5\/LEKTI regulation. Int J Mol Sci. 2022;23:8687. https:\/\/doi.org\/10.3390\/ijms23158687.","journal-title":"Int J Mol Sci"},{"key":"1497_CR108","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2010.03.013","volume":"141","author":"X Cheng","year":"2010","unstructured":"Cheng X, Jin J, Hu L, Shen D, Dong X, Samie MA, et al. TRP Channel regulates EGFR signaling in Hair Morphogenesis and Skin Barrier Formation. Cell. 2010;141:331. https:\/\/doi.org\/10.1016\/j.cell.2010.03.013.","journal-title":"Cell"},{"key":"1497_CR109","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1096\/fj.14-251314","volume":"29","author":"R Aijima","year":"2015","unstructured":"Aijima R, Wang B, Takao T, Mihara H, Kashio M, Ohsaki Y, et al. The thermosensitive TRPV3 channel contributes to rapid wound healing in oral epithelia. FASEB J. 2015;29:182\u201392. https:\/\/doi.org\/10.1096\/fj.14-251314.","journal-title":"FASEB J"},{"key":"1497_CR110","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.apjtb.2016.05.006","volume":"6","author":"JH Nam","year":"2016","unstructured":"Nam JH, Jung HW, Chin Y-W, Kim WK, Bae HS. Modulatory effects of the fruits of Tribulus terrestris L. on the function of atopic dermatitis-related calcium channels, Orai1 and TRPV3. Asian Pac J Trop Biomed. 2016;6:580\u20135. https:\/\/doi.org\/10.1016\/j.apjtb.2016.05.006.","journal-title":"Asian Pac J Trop Biomed"},{"key":"1497_CR111","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1080\/13880209.2017.1300819","volume":"55","author":"JH Nam","year":"2017","unstructured":"Nam JH, Jung HW, Chin Y-W, Yang W-M, Bae HS, Kim WK. Spirodela polyrhiza extract modulates the activation of atopic dermatitis-related ion channels, Orai1 and TRPV3, and inhibits mast cell degranulation. Pharm Biol. 2017;55:1324\u20139. https:\/\/doi.org\/10.1080\/13880209.2017.1300819.","journal-title":"Pharm Biol"},{"key":"1497_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114453","volume":"281","author":"E-Y Kim","year":"2021","unstructured":"Kim E-Y, Hong S, Kim J-H, Kim M, Lee Y, Sohn Y, et al. Effects of chloroform fraction of Fritillariae Thunbergii Bulbus on atopic symptoms in a DNCB-induced atopic dermatitis-like skin lesion model and in vitro models. J Ethnopharmacol. 2021;281:114453. https:\/\/doi.org\/10.1016\/j.jep.2021.114453.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR113","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ctim.2013.12.003","volume":"22","author":"J-F Lin","year":"2014","unstructured":"Lin J-F, Liu P-H, Huang T-P, Lien AS-Y, Ou L-S, Yu C-H, et al. Characteristics and prescription patterns of traditional Chinese medicine in atopic dermatitis patients: ten-year experiences at a medical center in Taiwan. Complement Ther Med. 2014;22:141\u20137. https:\/\/doi.org\/10.1016\/j.ctim.2013.12.003.","journal-title":"Complement Ther Med"},{"key":"1497_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153453","volume":"82","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xian Y-F, Loo S, Chan WY, Liu L, Lin Z-X. Anti-atopic dermatitis effects of dictamni cortex: studies on in vitro and in vivo experimental models. Phytomedicine. 2021;82:153453. https:\/\/doi.org\/10.1016\/j.phymed.2020.153453.","journal-title":"Phytomedicine"},{"key":"1497_CR115","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1248\/bpb.b19-00088","volume":"43","author":"M Fujii","year":"2020","unstructured":"Fujii M. Current understanding of pathophysiological mechanisms of atopic dermatitis: interactions among skin barrier dysfunction, immune abnormalities and pruritus. Biol Pharm Bull. 2020;43:12\u20139. https:\/\/doi.org\/10.1248\/bpb.b19-00088.","journal-title":"Biol Pharm Bull"},{"key":"1497_CR116","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/jdv.15973","volume":"34","author":"G Yosipovitch","year":"2020","unstructured":"Yosipovitch G, Berger T, Fassett MS. Neuroimmune interactions in chronic itch of atopic dermatitis. J Eur Acad Dermatol Venereol. 2020;34:239\u201350. https:\/\/doi.org\/10.1111\/jdv.15973.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1497_CR117","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12016-015-8488-5","volume":"51","author":"NK Mollanazar","year":"2016","unstructured":"Mollanazar NK, Smith PK, Yosipovitch G. Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol. 2016;51:263\u201392. https:\/\/doi.org\/10.1007\/s12016-015-8488-5.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1497_CR118","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1016\/j.neuroimage.2011.10.099","volume":"59","author":"ADP Papoiu","year":"2012","unstructured":"Papoiu ADP, Coghill RC, Kraft RA, Wang H, Yosipovitch G. A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. Neuroimage. 2012;59:3611\u201323. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.10.099.","journal-title":"Neuroimage"},{"key":"1497_CR119","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1523\/JNEUROSCI.2862-07.2007","volume":"27","author":"S Davidson","year":"2007","unstructured":"Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler GJ. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci. 2007;27:10007\u201314. https:\/\/doi.org\/10.1523\/JNEUROSCI.2862-07.2007.","journal-title":"J Neurosci"},{"key":"1497_CR120","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nn.2292","volume":"12","author":"S Davidson","year":"2009","unstructured":"Davidson S, Zhang X, Khasabov SG, Simone DA, Giesler GJ. Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons. Nat Neurosci. 2009;12:544\u20136. https:\/\/doi.org\/10.1038\/nn.2292.","journal-title":"Nat Neurosci"},{"key":"1497_CR121","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/exd.14464","volume":"31","author":"L Tang","year":"2022","unstructured":"Tang L, Gao J, Cao X, Chen L, Wang H, Ding H. TRPV1 mediates itch-associated scratching and skin barrier dysfunction in DNFB-induced atopic dermatitis mice. Exp Dermatol. 2022;31:398\u2013405. https:\/\/doi.org\/10.1111\/exd.14464.","journal-title":"Exp Dermatol"},{"key":"1497_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010420","volume":"24","author":"O Mahmoud","year":"2022","unstructured":"Mahmoud O, Soares GB, Yosipovitch G. Transient receptor potential channels and itch. Int J Mol Sci. 2022;24:420. https:\/\/doi.org\/10.3390\/ijms24010420.","journal-title":"Int J Mol Sci"},{"key":"1497_CR123","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.alit.2022.04.003","volume":"71","author":"M Tominaga","year":"2022","unstructured":"Tominaga M, Takamori K. Peripheral itch sensitization in atopic dermatitis. Allergol Int. 2022;71:265\u201377. https:\/\/doi.org\/10.1016\/j.alit.2022.04.003.","journal-title":"Allergol Int"},{"key":"1497_CR124","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1038\/sj.bjp.0706440","volume":"147","author":"ME Parsons","year":"2006","unstructured":"Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol. 2006;147:S127\u201335. https:\/\/doi.org\/10.1038\/sj.bjp.0706440.","journal-title":"Br J Pharmacol"},{"key":"1497_CR125","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2004.01.019","volume":"361","author":"BM Kim","year":"2004","unstructured":"Kim BM, Lee SH, Shim WS, Oh U. Histamine-induced Ca2+ influx via the PLA2\/lipoxygenase\/TRPV1 pathway in rat sensory neurons. Neurosci Lett. 2004;361:159\u201362. https:\/\/doi.org\/10.1016\/j.neulet.2004.01.019.","journal-title":"Neurosci Lett"},{"key":"1497_CR126","doi-asserted-by":"publisher","first-page":"112624","DOI":"10.1016\/j.physbeh.2019.112624","volume":"210","author":"BH Kim","year":"2019","unstructured":"Kim BH, Lee W-J, Sanjel B, Cho K, Son YK, Park HY, et al. Extracts of the leaves of Pyrus ussuriensis Maxim. Alleviate itch sensation via TSLP-dependent manner in mouse models of atopic dermatitis. Physiol Behav. 2019;210:112624. https:\/\/doi.org\/10.1016\/j.physbeh.2019.112624.","journal-title":"Physiol Behav"},{"key":"1497_CR127","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jaci.2023.08.017","volume":"153","author":"B Kim","year":"2024","unstructured":"Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, et al. Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms, and therapeutic targets in atopic diseases. J Allergy Clin Immunol. 2024;153:879\u201393. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.017.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR128","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","volume":"138","author":"T Werfel","year":"2016","unstructured":"Werfel T, Allam J-P, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:336\u201349. https:\/\/doi.org\/10.1016\/j.jaci.2016.06.010.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR129","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","volume":"171","author":"LK Oetjen","year":"2017","unstructured":"Oetjen LK, Mack MR, Feng J, Whelan TM, Niu H, Guo CJ, et al. Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch. Cell. 2017;171:217-228.e13. https:\/\/doi.org\/10.1016\/j.cell.2017.08.006.","journal-title":"Cell"},{"key":"1497_CR130","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","volume":"133","author":"F Cevikbas","year":"2014","unstructured":"Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 2014;133:448\u201360. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.048.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR131","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.08.006","volume":"96","author":"Y Imai","year":"2019","unstructured":"Imai Y. Interleukin-33 in atopic dermatitis. J Dermatol Sci. 2019;96:2\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2019.08.006.","journal-title":"J Dermatol Sci"},{"key":"1497_CR132","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.jaci.2022.03.010","volume":"149","author":"M Steinhoff","year":"2022","unstructured":"Steinhoff M, Ahmad F, Pandey A, Datsi A, AlHammadi A, Al-Khawaga S, et al. Neuroimmune communication regulating pruritus in atopic dermatitis. J Allergy Clin Immunol. 2022;149:1875\u201398. https:\/\/doi.org\/10.1016\/j.jaci.2022.03.010.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR133","doi-asserted-by":"publisher","first-page":"E7572","DOI":"10.1073\/pnas.1606608113","volume":"113","author":"B Liu","year":"2016","unstructured":"Liu B, Tai Y, Achanta S, Kaelberer MM, Caceres AI, Shao X, et al. IL-33\/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc Natl Acad Sci U S A. 2016;113:E7572\u20139. https:\/\/doi.org\/10.1073\/pnas.1606608113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1497_CR134","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","volume":"155","author":"SR Wilson","year":"2013","unstructured":"Wilson SR, Th\u00e9 L, Batia LM, Beattie K, Katibah GE, McClain SP, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155:285\u201395. https:\/\/doi.org\/10.1016\/j.cell.2013.08.057.","journal-title":"Cell"},{"key":"1497_CR135","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/JIR.S425978","volume":"17","author":"NK Kordulewska","year":"2024","unstructured":"Kordulewska NK, Kr\u00f3l-Grzyma\u0142a A. The effect of osthole on transient receptor potential channels: a possible alternative therapy for atopic dermatitis. J Inflamm Res. 2024;17:881\u201398. https:\/\/doi.org\/10.2147\/JIR.S425978.","journal-title":"J Inflamm Res"},{"key":"1497_CR136","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.chmed.2024.01.003","volume":"17","author":"S He","year":"2024","unstructured":"He S, Liang X, Chen W, Nima Y, Li Y, Gu Z, et al. Osthole ameliorates chronic pruritus in 2,4-dichloronitrobenzene-induced atopic dermatitis by inhibiting IL-31 production. Chin Herb Med. 2024;17:368\u201379. https:\/\/doi.org\/10.1016\/j.chmed.2024.01.003.","journal-title":"Chin Herb Med"},{"key":"1497_CR137","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/bjd.18025","volume":"181","author":"S St\u00e4nder","year":"2019","unstructured":"St\u00e4nder S, Yosipovitch G. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus. Br J Dermatol. 2019;181:932\u20138. https:\/\/doi.org\/10.1111\/bjd.18025.","journal-title":"Br J Dermatol"},{"key":"1497_CR138","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2147\/CCID.S306557","volume":"14","author":"DA Paramita","year":"2021","unstructured":"Paramita DA, Nasution K, Lubis NZ. Relationship of substance P with the degree of atopic dermatitis severity. CCID. 2021;14:551\u20135. https:\/\/doi.org\/10.2147\/CCID.S306557.","journal-title":"CCID"},{"key":"1497_CR139","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1017\/S0007114511006544","volume":"108","author":"Y Panahi","year":"2012","unstructured":"Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, et al. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2012;108:1272\u20139. https:\/\/doi.org\/10.1017\/S0007114511006544.","journal-title":"Br J Nutr"},{"key":"1497_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynpai.2019.100032","volume":"6","author":"K Chung","year":"2019","unstructured":"Chung K, Pitcher T, Grant AD, Hewitt E, Lindstrom E, Malcangio M. Cathepsin S acts via protease-activated receptor 2 to activate sensory neurons and induce itch-like behaviour. Neurobiol Pain. 2019;6:100032. https:\/\/doi.org\/10.1016\/j.ynpai.2019.100032.","journal-title":"Neurobiol Pain"},{"key":"1497_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110003","volume":"117","author":"Y Ding","year":"2023","unstructured":"Ding Y, Ma T, Zhang Y, Zhao C, Wang C, Wang Z. Rosmarinic acid ameliorates skin inflammation and pruritus in allergic contact dermatitis by inhibiting mast cell-mediated MRGPRX2\/PLC\u03b31 signaling pathway. Int Immunopharmacol. 2023;117:110003. https:\/\/doi.org\/10.1016\/j.intimp.2023.110003.","journal-title":"Int Immunopharmacol"},{"key":"1497_CR142","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1021\/acsomega.3c09697","volume":"9","author":"J Zheng","year":"2024","unstructured":"Zheng J, Gu A, Kong L, Lu W, Xia J, Hu H, et al. Cimifugin relieves histamine-independent itch in atopic dermatitis via targeting the CQ receptor MrgprA3. ACS Omega. 2024;9:7239\u201348. https:\/\/doi.org\/10.1021\/acsomega.3c09697.","journal-title":"ACS Omega"},{"key":"1497_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118580","volume":"334","author":"T Yan","year":"2024","unstructured":"Yan T, Luo M, He J, Wang M, Ma Z, Zhao Z, et al. Artemisia argyi volatile oil ameliorates allergic contact dermatitis via modulating TRPA1\/CGRP signaling. J Ethnopharmacol. 2024;334:118580. https:\/\/doi.org\/10.1016\/j.jep.2024.118580.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR144","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5469125","volume":"2017","author":"J Yang","year":"2017","unstructured":"Yang J, Min S, Hong S. Therapeutic effects of fermented flax seed oil on NC\/Nga mice with atopic dermatitis-like skin lesions. Evid Based Complement Alternat Med. 2017;2017:5469125. https:\/\/doi.org\/10.1155\/2017\/5469125.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1497_CR145","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5142\/JGR.2008.32.1.033","volume":"32","author":"EA Bae","year":"2008","unstructured":"Bae EA, Trinh HT, Lee YC, Kim SW, Kim DH. Inhibitory Effect of Fermented Red Ginseng against Passive Cutaneous Anaphylaxis Reaction and Scratching behaviors in Mice. J Ginseng Res. 2008;32:33\u20138.","journal-title":"J Ginseng Res"},{"key":"1497_CR146","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jdermsci.2007.02.002","volume":"46","author":"M Tominaga","year":"2007","unstructured":"Tominaga M, Ozawa S, Ogawa H, Takamori K. A hypothetical mechanism of intraepidermal neurite formation in NC\/Nga mice with atopic dermatitis. J Dermatol Sci. 2007;46:199\u2013210. https:\/\/doi.org\/10.1016\/j.jdermsci.2007.02.002.","journal-title":"J Dermatol Sci"},{"key":"1497_CR147","first-page":"85","volume":"10","author":"C Pincelli","year":"2000","unstructured":"Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol. 2000;10:85\u201390.","journal-title":"Eur J Dermatol"},{"key":"1497_CR148","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jdermsci.2012.05.011","volume":"67","author":"A Matsuda","year":"2012","unstructured":"Matsuda A, Tanaka A, Pan W, Okamoto N, Oida K, Kingyo N, et al. Supplementation of the fermented soy product ImmuBalance\u2122 effectively reduces itching behavior of atopic NC\/Tnd mice. J Dermatol Sci. 2012;67:130\u20139. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.05.011.","journal-title":"J Dermatol Sci"},{"key":"1497_CR149","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1089\/jmf.2015.3489","volume":"19","author":"J Lee","year":"2016","unstructured":"Lee J, Choi YY, Kim MH, Han JM, Lee JE, Kim EH, et al. Topical application of Angelica sinensis improves pruritus and skin inflammation in mice with atopic dermatitis-like symptoms. J Med Food. 2016;19:98\u2013105. https:\/\/doi.org\/10.1089\/jmf.2015.3489.","journal-title":"J Med Food"},{"key":"1497_CR150","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/0974-8490.85002","volume":"3","author":"K Yamaura","year":"2011","unstructured":"Yamaura K, Shimada M, Ueno K. Anthocyanins from bilberry (Vaccinium myrtillus L.) alleviate pruritus in a mouse model of chronic allergic contact dermatitis. Pharmacogn Res. 2011;3:173\u20137. https:\/\/doi.org\/10.4103\/0974-8490.85002.","journal-title":"Pharmacogn Res"},{"key":"1497_CR151","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/jid.2011.182","volume":"131","author":"RL Gallo","year":"2011","unstructured":"Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol. 2011;131:1974\u201380. https:\/\/doi.org\/10.1038\/jid.2011.182.","journal-title":"J Invest Dermatol"},{"key":"1497_CR152","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1038\/jid.2010.123","volume":"130","author":"Y Lai","year":"2010","unstructured":"Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol. 2010;130:2211\u201321. https:\/\/doi.org\/10.1038\/jid.2010.123.","journal-title":"J Invest Dermatol"},{"key":"1497_CR153","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature14052","volume":"520","author":"S Naik","year":"2015","unstructured":"Naik S, Bouladoux N, Linehan JL, Han S-J, Harrison OJ, Wilhelm C, et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 2015;520:104\u20138. https:\/\/doi.org\/10.1038\/nature14052.","journal-title":"Nature"},{"key":"1497_CR154","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.immuni.2015.10.016","volume":"43","author":"TC Scharschmidt","year":"2015","unstructured":"Scharschmidt TC, Vasquez KS, Truong H-A, Gearty SV, Pauli ML, Nosbaum A, et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity. 2015;43:1011\u201321. https:\/\/doi.org\/10.1016\/j.immuni.2015.10.016.","journal-title":"Immunity"},{"key":"1497_CR155","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","volume":"134","author":"DYM Leung","year":"2014","unstructured":"Leung DYM, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134:769\u201379. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.008.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR156","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2133.1974.tb06447.x","volume":"90","author":"JJ Leyden","year":"1974","unstructured":"Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90:525\u201330. https:\/\/doi.org\/10.1111\/j.1365-2133.1974.tb06447.x.","journal-title":"Br J Dermatol"},{"key":"1497_CR157","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1101\/gr.131029.111","volume":"22","author":"HH Kong","year":"2012","unstructured":"Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22:850\u20139. https:\/\/doi.org\/10.1101\/gr.131029.111.","journal-title":"Genome Res"},{"key":"1497_CR158","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2020.1754706","volume":"8","author":"ZW Lipsky","year":"2020","unstructured":"Lipsky ZW, Marques CNH, German GK. Lipid depletion enables permeation of Staphylococcus aureus bacteria through human stratum corneum. Tissue Barriers. 2020;8:1754706. https:\/\/doi.org\/10.1080\/21688370.2020.1754706.","journal-title":"Tissue Barriers"},{"key":"1497_CR159","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.0022-202X.2004.22317.x","volume":"122","author":"N Nakagawa","year":"2004","unstructured":"Nakagawa N, Sakai S, Matsumoto M, Yamada K, Nagano M, Yuki T, et al. Relationship between NMF (lactate and potassium) content and the physical properties of the stratum corneum in healthy subjects. J Invest Dermatol. 2004;122:755\u201363. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.22317.x.","journal-title":"J Invest Dermatol"},{"key":"1497_CR160","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1039\/c4sm00137k","volume":"10","author":"S Bj\u00f6rklund","year":"2014","unstructured":"Bj\u00f6rklund S, Andersson JM, Pham QD, Nowacka A, Topgaard D, Sparr E. Stratum corneum molecular mobility in the presence of natural moisturizers. Soft Matter. 2014;10:4535\u201346. https:\/\/doi.org\/10.1039\/c4sm00137k.","journal-title":"Soft Matter"},{"key":"1497_CR161","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1046\/j.1523-1747.2000.00992.x","volume":"114","author":"S Sakai","year":"2000","unstructured":"Sakai S, Yasuda R, Sayo T, Ishikawa O, Inoue S. Hyaluronan exists in the normal stratum corneum. J Invest Dermatol. 2000;114:1184\u20137. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00992.x.","journal-title":"J Invest Dermatol"},{"key":"1497_CR162","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02744-21","volume":"10","author":"ZW Lipsky","year":"2022","unstructured":"Lipsky ZW, Patsy M, Marques CNH, German GK. Mechanisms and Implications of Bacterial Invasion across the Human Skin Barrier. Microbiol Spectr. 2022;10:e0274421. https:\/\/doi.org\/10.1128\/spectrum.02744-21.","journal-title":"Microbiol Spectr"},{"key":"1497_CR163","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature12655","volume":"503","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Mu\u00f1oz-Planillo R, Hasegawa M, et al. Staphylococcus \u03b4-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503:397\u2013401. https:\/\/doi.org\/10.1038\/nature12655.","journal-title":"Nature"},{"issue":"985\u201393","key":"1497_CR164","doi-asserted-by":"publisher","first-page":"993.e1","DOI":"10.1016\/j.jaci.2010.09.002","volume":"126","author":"AT Vu","year":"2010","unstructured":"Vu AT, Baba T, Chen X, Le TA, Kinoshita H, Xie Y, et al. Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway. J Allergy Clin Immunol. 2010;126(985\u201393):993.e1-3. https:\/\/doi.org\/10.1016\/j.jaci.2010.09.002.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR165","doi-asserted-by":"publisher","first-page":"R176","DOI":"10.1186\/ar2086","volume":"8","author":"S Kanangat","year":"2006","unstructured":"Kanangat S, Postlethwaite A, Hasty K, Kang A, Smeltzer M, Appling W, et al. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther. 2006;8:R176. https:\/\/doi.org\/10.1186\/ar2086.","journal-title":"Arthritis Res Ther"},{"key":"1497_CR166","doi-asserted-by":"publisher","unstructured":"Nakagawa S, Hillebrand GG, Nunez G. Rosmarinus officinalis L. (Rosemary) Extracts Containing Carnosic Acid and Carnosol are Potent Quorum Sensing Inhibitors of Staphylococcus aureus Virulence. Antibiotics (Basel). 2020;9:149. https:\/\/doi.org\/10.3390\/antibiotics9040149","DOI":"10.3390\/antibiotics9040149"},{"key":"1497_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2026.108296","volume":"212","author":"Y Wang","year":"2026","unstructured":"Wang Y, Luo S, Guo X, Jin M, Wang X, Li M, et al. Prim-O-glucosylcimifugin targets Staphylococcus aureus caseinolytic protease P to inhibit \u03b1-hemolysin expression and promote healing of MRSA-induced diabetic skin infections. Microb Pathog. 2026;212:108296. https:\/\/doi.org\/10.1016\/j.micpath.2026.108296.","journal-title":"Microb Pathog"},{"key":"1497_CR168","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.bbamem.2012.09.004","volume":"1828","author":"J-J Koh","year":"2013","unstructured":"Koh J-J, Qiu S, Zou H, Lakshminarayanan R, Li J, Zhou X, et al. Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting. Biochim Biophys Acta. 2013;1828:834\u201344. https:\/\/doi.org\/10.1016\/j.bbamem.2012.09.004.","journal-title":"Biochim Biophys Acta"},{"key":"1497_CR169","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19524","volume":"13","author":"GA Al-Hamoud","year":"2025","unstructured":"Al-Hamoud GA, Amina M, Alrashoudi RH, Mateen A, Maqsood F, Al-Yousef HM. Unveiling phenolic content, antibacterial, and antibiofilm potential of sacha inchi (Plukenetia volubilis L.) seed shell extracts against Staphylococcus aureus. PeerJ. 2025;13:e19524. https:\/\/doi.org\/10.7717\/peerj.19524.","journal-title":"PeerJ"},{"key":"1497_CR170","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3746\/jkfn.2004.33.10.1601","volume":"33","author":"C-H Jeong","year":"2004","unstructured":"Jeong C-H, Bae Y-I, Shim K-H, Choi J-S. DPPH Radical Scavenging Effect and Antimicrobial Activities of Plantain (Plantago asiatica L.) Extracts. J Korean Soc Food Sci Nutr. 2004;33:1601\u20135. https:\/\/doi.org\/10.3746\/jkfn.2004.33.10.1601.","journal-title":"J Korean Soc Food Sci Nutr"},{"key":"1497_CR171","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/cells13191639","volume":"13","author":"AR Maskey","year":"2024","unstructured":"Maskey AR, Kopulos D, Kwan M, Reyes N, Figueroa C, Mo X, et al. Berberine inhibits the inflammatory response induced by Staphylococcus aureus isolated from atopic eczema patients via the TNF-\u03b1\/inflammation\/RAGE pathways. Cells. 2024;13:1639. https:\/\/doi.org\/10.3390\/cells13191639.","journal-title":"Cells"},{"key":"1497_CR172","doi-asserted-by":"publisher","unstructured":"Peng Z, Wei X-Y, Zeng X, Anwaier G, Zhou X, Shi B-J. A berberine-loaded hydrogel for the treatment of atopic dermatitis through antibacterial activity, inhibition of inflammation and modulation of oxidative stress. Front Immunol. 17:1740911. https:\/\/doi.org\/10.3389\/fimmu.2026.1740911","DOI":"10.3389\/fimmu.2026.1740911"},{"key":"1497_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1668089","volume":"16","author":"A Wang","year":"2025","unstructured":"Wang A, Chen T, Zhang H, Yang Y, Cheng X, Chen D, et al. Mechanistic study of Jiawei Zicao Plaster in atopic dermatitis via IL-17 signaling pathway and skin microbiome modulation. Front Microbiol. 2025;16:1668089. https:\/\/doi.org\/10.3389\/fmicb.2025.1668089.","journal-title":"Front Microbiol"},{"key":"1497_CR174","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijwd.2020.03.042","volume":"6","author":"AA Hebert","year":"2020","unstructured":"Hebert AA. Oxidative stress as a treatment target in atopic dermatitis: the role of furfuryl palmitate in mild-to-moderate atopic dermatitis. Int J Womens Dermatol. 2020;6:331\u20133. https:\/\/doi.org\/10.1016\/j.ijwd.2020.03.042.","journal-title":"Int J Womens Dermatol"},{"key":"1497_CR175","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.0022-202X.2005.23624.x","volume":"124","author":"M Mizuashi","year":"2005","unstructured":"Mizuashi M, Ohtani T, Nakagawa S, Aiba S. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J Invest Dermatol Elsevier. 2005;124:579\u201386. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23624.x.","journal-title":"J Invest Dermatol Elsevier"},{"key":"1497_CR176","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.fct.2013.02.038","volume":"61","author":"E Corsini","year":"2013","unstructured":"Corsini E, Galbiati V, Nikitovic D, Tsatsakis AM. Role of oxidative stress in chemical allergens induced skin cells activation. Food Chem Toxicol. 2013;61:74\u201381. https:\/\/doi.org\/10.1016\/j.fct.2013.02.038.","journal-title":"Food Chem Toxicol"},{"key":"1497_CR177","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1568010054526386","volume":"4","author":"Y Okayama","year":"2005","unstructured":"Okayama Y. Oxidative stress in allergic and inflammatory skin diseases. Curr Drug Targets Inflamm Allergy. 2005;4:517\u20139. https:\/\/doi.org\/10.2174\/1568010054526386.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"1497_CR178","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/antiox9030196","volume":"9","author":"L Bertino","year":"2020","unstructured":"Bertino L, Guarneri F, Cannav\u00f2 SP, Casciaro M, Pioggia G, Gangemi S. Oxidative stress and atopic dermatitis. Antioxidants. 2020;9:196. https:\/\/doi.org\/10.3390\/antiox9030196.","journal-title":"Antioxidants"},{"key":"1497_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042137","volume":"22","author":"A Wysocka","year":"2021","unstructured":"Wysocka A, Zwolak A. The relevance of noncoding DNA variations of paraoxonase gene cluster in atherosclerosis-related diseases. Int J Mol Sci. 2021;22:2137. https:\/\/doi.org\/10.3390\/ijms22042137.","journal-title":"Int J Mol Sci"},{"key":"1497_CR180","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","volume":"7","author":"K Lingappan","year":"2018","unstructured":"Lingappan K. NF-\u03baB in oxidative stress. Curr Opin Toxicol. 2018;7:81\u20136. https:\/\/doi.org\/10.1016\/j.cotox.2017.11.002.","journal-title":"Curr Opin Toxicol"},{"key":"1497_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Sig Transduct Target Ther. 2017;2:1\u20139. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Sig Transduct Target Ther"},{"key":"1497_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113601","volume":"154","author":"AQ Khan","year":"2022","unstructured":"Khan AQ, Agha MV, Sheikhan KSAM, Younis SM, Tamimi MA, Alam M, et al. Targeting deregulated oxidative stress in skin inflammatory diseases: an update on clinical importance. Biomed Pharmacother. 2022;154:113601. https:\/\/doi.org\/10.1016\/j.biopha.2022.113601.","journal-title":"Biomed Pharmacother"},{"key":"1497_CR183","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ptr.5239","volume":"29","author":"SM El-Bahr","year":"2015","unstructured":"El-Bahr SM. Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1. Phytother Res. 2015;29:134\u201340. https:\/\/doi.org\/10.1002\/ptr.5239.","journal-title":"Phytother Res"},{"key":"1497_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060717","volume":"11","author":"OS Sultan","year":"2022","unstructured":"Sultan OS, Kantilal HK, Khoo SP, Davamani AF, Eusufzai SZ, Rashid F, et al. The potential of \u03b1-mangostin from Garcinia mangostana as an effective antimicrobial agent-a systematic review and meta-analysis. Antibiotics (Basel). 2022;11:717. https:\/\/doi.org\/10.3390\/antibiotics11060717.","journal-title":"Antibiotics (Basel)"},{"key":"1497_CR185","doi-asserted-by":"publisher","unstructured":"So-In C, Sunthamala N. Treatment efficacy of Thunbergia laurifolia, Curcuma longa, Garcinia mangostana, and Andrographis paniculata extracts in Staphylococcus aureus-induced rabbit dermatitis model. Vet World. 2022. https:\/\/doi.org\/10.14202\/vetworld.2022.188-197","DOI":"10.14202\/vetworld.2022.188-197"},{"key":"1497_CR186","doi-asserted-by":"publisher","first-page":"7676","DOI":"10.3390\/ijms25147676","volume":"25","author":"X Chen","year":"2024","unstructured":"Chen X, Wu Y, Jia R, Fang Y, Cao K, Yang X, et al. Antioxidant activity and the therapeutic effect of sinomenine hydrochloride-loaded liposomes-in-hydrogel on atopic dermatitis. Int J Mol Sci. 2024;25:7676. https:\/\/doi.org\/10.3390\/ijms25147676.","journal-title":"Int J Mol Sci"},{"key":"1497_CR187","doi-asserted-by":"publisher","DOI":"10.3390\/life12020299","volume":"12","author":"FJ Navarro-Trivi\u00f1o","year":"2022","unstructured":"Navarro-Trivi\u00f1o FJ, Ay\u00e9n-Rodr\u00edguez \u00c1. Study of hypersensitivity to Malassezia furfur in patients with atopic dermatitis with head and neck pattern: is it useful as a biomarker and therapeutic indicator in these patients? Life (Basel). 2022;12:299. https:\/\/doi.org\/10.3390\/life12020299.","journal-title":"Life (Basel)"},{"key":"1497_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11050766","volume":"11","author":"M Mazur","year":"2023","unstructured":"Mazur M, Tomczak H, \u0141odyga M, Plagens-Rotman K, Merks P, Czarnecka-Operacz M. The intestinal and skin microbiome in patients with atopic dermatitis and their influence on the course of the disease: a literature review. Healthcare (Basel). 2023;11:766. https:\/\/doi.org\/10.3390\/healthcare11050766.","journal-title":"Healthcare (Basel)"},{"key":"1497_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720393","volume":"12","author":"Z Fang","year":"2021","unstructured":"Fang Z, Li L, Zhang H, Zhao J, Lu W, Chen W. Gut microbiota, probiotics, and their interactions in prevention and treatment of atopic dermatitis: a review. Front Immunol. 2021;12:720393. https:\/\/doi.org\/10.3389\/fimmu.2021.720393.","journal-title":"Front Immunol"},{"key":"1497_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084228","volume":"22","author":"DH Park","year":"2021","unstructured":"Park DH, Kim JW, Park H-J, Hahm D-H. Comparative analysis of the microbiome across the gut-skin axis in atopic dermatitis. Int J Mol Sci. 2021;22:4228. https:\/\/doi.org\/10.3390\/ijms22084228.","journal-title":"Int J Mol Sci"},{"key":"1497_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang R-F. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774. https:\/\/doi.org\/10.3389\/fimmu.2022.812774.","journal-title":"Front Immunol"},{"key":"1497_CR192","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.3390\/ijms21207488","volume":"21","author":"M Tokuyama","year":"2020","unstructured":"Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. 2020;21:7488. https:\/\/doi.org\/10.3390\/ijms21207488.","journal-title":"Int J Mol Sci"},{"key":"1497_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02125-1","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X, Shi L, Sun T, Guo K, Geng S. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol. 2021;21:78. https:\/\/doi.org\/10.1186\/s12866-021-02125-1.","journal-title":"BMC Microbiol"},{"key":"1497_CR194","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41385-022-00524-9","volume":"15","author":"A Trompette","year":"2022","unstructured":"Trompette A, Pernot J, Perdijk O, Alqahtani RAA, Domingo JS, Camacho-Mu\u00f1oz D, et al. Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation. Mucosal Immunol. 2022;15:908\u201326. https:\/\/doi.org\/10.1038\/s41385-022-00524-9.","journal-title":"Mucosal Immunol"},{"key":"1497_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1083432","volume":"13","author":"X Xiao","year":"2022","unstructured":"Xiao X, Hu X, Yao J, Cao W, Zou Z, Wang L, et al. The role of short-chain fatty acids in inflammatory skin diseases. Front Microbiol. 2022;13:1083432. https:\/\/doi.org\/10.3389\/fmicb.2022.1083432.","journal-title":"Front Microbiol"},{"key":"1497_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.962787","volume":"9","author":"Y Li","year":"2022","unstructured":"Li Y, Li Q, Cao Z, Wu J. The causal association of polyunsaturated fatty acids with allergic disease: a two-sample Mendelian randomization study. Front Nutr. 2022;9:962787. https:\/\/doi.org\/10.3389\/fnut.2022.962787.","journal-title":"Front Nutr"},{"key":"1497_CR197","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1016\/j.febslet.2014.03.019","volume":"588","author":"MM Kosiewicz","year":"2014","unstructured":"Kosiewicz MM, Dryden GW, Chhabra A, Alard P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett. 2014;588:4195\u2013206. https:\/\/doi.org\/10.1016\/j.febslet.2014.03.019.","journal-title":"FEBS Lett"},{"key":"1497_CR198","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00007","volume":"9","author":"MJE Visser","year":"2019","unstructured":"Visser MJE, Kell DB, Pretorius E. Bacterial dysbiosis and translocation in psoriasis vulgaris. Front Cell Infect Microbiol. 2019;9:7. https:\/\/doi.org\/10.3389\/fcimb.2019.00007.","journal-title":"Front Cell Infect Microbiol"},{"key":"1497_CR199","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.clindermatol.2021.08.021","volume":"39","author":"S Sinha","year":"2021","unstructured":"Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021;39:829\u201339. https:\/\/doi.org\/10.1016\/j.clindermatol.2021.08.021.","journal-title":"Clin Dermatol"},{"key":"1497_CR200","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/microorganisms9020353","volume":"9","author":"B De Pessemier","year":"2021","unstructured":"De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms. 2021;9:353. https:\/\/doi.org\/10.3390\/microorganisms9020353.","journal-title":"Microorganisms"},{"key":"1497_CR201","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13555-020-00466-9","volume":"11","author":"G Chen","year":"2021","unstructured":"Chen G, Chen Z, Fan X, Jin Y, Li X, Wu S, et al. Gut\u2013brain\u2013skin axis in psoriasis: a review. Dermatol Ther. 2021;11:25\u201338. https:\/\/doi.org\/10.1007\/s13555-020-00466-9.","journal-title":"Dermatol Ther"},{"key":"1497_CR202","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4168\/aair.2018.10.4.354","volume":"10","author":"SY Lee","year":"2018","unstructured":"Lee SY, Lee E, Park YM, Hong SJ. Microbiome in the Gut-Skin Axis in Atopic Dermatitis. Allergy Asthma Immunol Res. 2018;10:354\u201362. https:\/\/doi.org\/10.4168\/aair.2018.10.4.354.","journal-title":"Allergy Asthma Immunol Res"},{"key":"1497_CR203","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1021\/acs.jafc.3c06015","volume":"72","author":"D Li","year":"2024","unstructured":"Li D, Luo Z-B, Zhu J, Wang J-X, Jin Z-Y, Qi S, et al. Ginsenoside F2-mediated intestinal microbiota and its metabolite propionic acid positively impact the gut-skin axis in atopic dermatitis mice. J Agric Food Chem. 2024;72:339\u201350. https:\/\/doi.org\/10.1021\/acs.jafc.3c06015.","journal-title":"J Agric Food Chem"},{"key":"1497_CR204","doi-asserted-by":"publisher","unstructured":"He X, McLean JS, Edlund A, Yooseph S, Hall AP, Liu S-Y, et al. Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle. Proceedings of the National Academy of Sciences. 2015;112:244\u20139. https:\/\/doi.org\/10.1073\/pnas.1419038112","DOI":"10.1073\/pnas.1419038112"},{"key":"1497_CR205","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/all.12549","volume":"70","author":"L Nylund","year":"2015","unstructured":"Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy. 2015;70:241\u20134. https:\/\/doi.org\/10.1111\/all.12549.","journal-title":"Allergy"},{"key":"1497_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1573135","volume":"16","author":"Z-Q Hu","year":"2025","unstructured":"Hu Z-Q, Xie S-S, Zhou M-Y, Chen Y-C, Zhou F-M, Ding Z-S, et al. Senecio scandens Buch.-Ham. polysaccharides exert anti-atopic dermatitis effects by modulating gut microbiota and the MAPK\/NF-\u03baB pathway. Front Pharmacol. 2025;16:1573135. https:\/\/doi.org\/10.3389\/fphar.2025.1573135.","journal-title":"Front Pharmacol"},{"key":"1497_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112479","volume":"137","author":"L Zhang","year":"2024","unstructured":"Zhang L, Chen N, Liao Y, Kong Y, Yang X, Zhan M, et al. Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis. Int Immunopharmacol. 2024;137:112479. https:\/\/doi.org\/10.1016\/j.intimp.2024.112479.","journal-title":"Int Immunopharmacol"},{"key":"1497_CR208","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jaci.2008.07.011","volume":"122","author":"K Wickens","year":"2008","unstructured":"Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788\u201394. https:\/\/doi.org\/10.1016\/j.jaci.2008.07.011.","journal-title":"J Allergy Clin Immunol"},{"key":"1497_CR209","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025091","volume":"100","author":"Y-J Su","year":"2021","unstructured":"Su Y-J, Luo S-D, Hsu C-Y, Kuo H-C. Differences in gut microbiota between allergic rhinitis, atopic dermatitis, and skin urticaria. Medicine (Baltimore). 2021;100:e25091. https:\/\/doi.org\/10.1097\/MD.0000000000025091.","journal-title":"Medicine (Baltimore)"},{"key":"1497_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26063","volume":"10","author":"F Shen","year":"2024","unstructured":"Shen F, Gao C, Wang M, Ding X, Zhao H, Zhou M, et al. Therapeutic effects of the Qingre-Qushi recipe on atopic dermatitis through the regulation of gut microbiota and skin inflammation. Heliyon. 2024;10:e26063. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26063.","journal-title":"Heliyon"},{"key":"1497_CR211","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1248\/bpb.29.1862","volume":"29","author":"EA Bae","year":"2006","unstructured":"Bae EA, Han MJ, Shin YW, Kim DH. Inhibitory effects of Korean Red Ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol Pharm Bull. 2006;29:1862\u20137. https:\/\/doi.org\/10.1248\/bpb.29.1862.","journal-title":"Biol Pharm Bull"},{"key":"1497_CR212","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.intimp.2010.11.022","volume":"11","author":"HS Kim","year":"2011","unstructured":"Kim HS, Kim DH, Kim BK, Yoon SK, Kim MH, Lee JY, et al. Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC\/Nga mice. Int Immunopharmacol. 2011;11:280\u20135. https:\/\/doi.org\/10.1016\/j.intimp.2010.11.022.","journal-title":"Int Immunopharmacol"},{"key":"1497_CR213","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29174064","volume":"29","author":"SS Ahn","year":"2024","unstructured":"Ahn SS, Yeo H, Jung E, Kim TY, Han J, Lee YH, et al. Saikosaponin A recovers impaired filaggrin levels in inflamed skin by downregulating the expression of FRA1 and c-Jun. Molecules. 2024;29:4064. https:\/\/doi.org\/10.3390\/molecules29174064.","journal-title":"Molecules"},{"key":"1497_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105001","volume":"91","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ma H, Quaisie J, Gu C, Guo L, Liu D, et al. Tea saponin extracted from seed pomace of Camellia oleifera Abel ameliorates DNCB-induced atopic dermatitis-like symptoms in BALB\/c mice. J Funct Foods. 2022;91:105001. https:\/\/doi.org\/10.1016\/j.jff.2022.105001.","journal-title":"J Funct Foods"},{"key":"1497_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116344","volume":"309","author":"X Bai","year":"2023","unstructured":"Bai X, Rao X, Wang Y, Shen H, Jin X. A homogeneous Lonicera japonica polysaccharide alleviates atopic dermatitis by promoting Nrf2 activation and NLRP3 inflammasome degradation via p62. J Ethnopharmacol. 2023;309:116344. https:\/\/doi.org\/10.1016\/j.jep.2023.116344.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118677","volume":"335","author":"J Liao","year":"2024","unstructured":"Liao J, Zhao W, Zhang Y, Zou Z, Zhang Q, Chen D, et al. Dendrobium officinale Kimura et Migo polysaccharide ameliorated DNFB-induced atopic dermatitis in mice associated with suppressing MAPK\/NF-\u03baB\/STAT3 signaling pathways. J Ethnopharmacol. 2024;335:118677. https:\/\/doi.org\/10.1016\/j.jep.2024.118677.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR217","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/pharmaceutics17081058","volume":"17","author":"Z Qiu","year":"2025","unstructured":"Qiu Z, Zhang M, Du H, Wang Y, Shao X, Fu J, et al. A sponge-like polysaccharide from pine pollen: structural features and therapeutic potential in DNCB-induced atopic dermatitis models. Pharmaceutics. 2025;17:1058. https:\/\/doi.org\/10.3390\/pharmaceutics17081058.","journal-title":"Pharmaceutics"},{"key":"1497_CR218","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.fct.2017.10.025","volume":"110","author":"JK Choi","year":"2017","unstructured":"Choi JK, Jang YH, Lee S, Lee S-R, Choi Y-A, Jin M, et al. Chrysin attenuates atopic dermatitis by suppressing inflammation of keratinocytes. Food Chem Toxicol. 2017;110:142\u201350. https:\/\/doi.org\/10.1016\/j.fct.2017.10.025.","journal-title":"Food Chem Toxicol"},{"key":"1497_CR219","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.3390\/ijms21197348","volume":"21","author":"H Yeo","year":"2020","unstructured":"Yeo H, Lee YH, Koh D, Lim Y, Shin SY. Chrysin inhibits NF-\u03baB-dependent CCL5 transcription by targeting I\u03baB kinase in the atopic dermatitis-like inflammatory microenvironment. Int J Mol Sci. 2020;21:7348. https:\/\/doi.org\/10.3390\/ijms21197348.","journal-title":"Int J Mol Sci"},{"key":"1497_CR220","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094350","volume":"22","author":"H Yeo","year":"2021","unstructured":"Yeo H, Lee YH, Ahn SS, Jung E, Lim Y, Shin SY. Chrysin inhibits TNF\u03b1-induced TSLP expression through downregulation of EGR1 expression in keratinocytes. Int J Mol Sci. 2021;22:4350. https:\/\/doi.org\/10.3390\/ijms22094350.","journal-title":"Int J Mol Sci"},{"key":"1497_CR221","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/exd.12685","volume":"24","author":"V Karuppagounder","year":"2015","unstructured":"Karuppagounder V, Arumugam S, Thandavarayan RA, Pitchaimani V, Sreedhar R, Afrin R, et al. Modulation of HMGB1 translocation and RAGE\/NF\u03baB cascade by quercetin treatment mitigates atopic dermatitis in NC\/Nga transgenic mice. Exp Dermatol. 2015;24:418\u201323. https:\/\/doi.org\/10.1111\/exd.12685.","journal-title":"Exp Dermatol"},{"key":"1497_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105676","volume":"74","author":"D-D Hou","year":"2019","unstructured":"Hou D-D, Zhang W, Gao Y-L, Sun Y-Z, Wang H-X, Qi R-Q, et al. Anti-inflammatory effects of quercetin in a mouse model of MC903-induced atopic dermatitis. Int Immunopharmacol. 2019;74:105676. https:\/\/doi.org\/10.1016\/j.intimp.2019.105676.","journal-title":"Int Immunopharmacol"},{"key":"1497_CR223","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10753-019-01126-7","volume":"43","author":"S Sharma","year":"2020","unstructured":"Sharma S, Sethi GS, Naura AS. Curcumin ameliorates ovalbumin-induced atopic dermatitis and blocks the progression of atopic march in mice. Inflammation. 2020;43:358\u201369. https:\/\/doi.org\/10.1007\/s10753-019-01126-7.","journal-title":"Inflammation"},{"key":"1497_CR224","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.05092","volume":"34","author":"S Sharma","year":"2020","unstructured":"Sharma S, Naura AS. Efficacy of the curcumin to ameliorate ovalbumin induced atopic dermatitis and progression of atopic march in mice. FASEB J. 2020;34:1\u20131. https:\/\/doi.org\/10.1096\/fasebj.2020.34.s1.05092.","journal-title":"FASEB J"},{"key":"1497_CR225","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/molecules28010293","volume":"28","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang P, Zhang J, Hong T. Inhibitory effect of bisdemethoxycurcumin on DNCB-induced atopic dermatitis in mice. Molecules. 2023;28:293. https:\/\/doi.org\/10.3390\/molecules28010293.","journal-title":"Molecules"},{"key":"1497_CR226","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.intimp.2014.10.014","volume":"23","author":"V Karuppagounder","year":"2014","unstructured":"Karuppagounder V, Arumugam S, Thandavarayan RA, Pitchaimani V, Sreedhar R, Afrin R, et al. Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice. Int Immunopharmacol. 2014;23:617\u201323. https:\/\/doi.org\/10.1016\/j.intimp.2014.10.014.","journal-title":"Int Immunopharmacol"},{"key":"1497_CR227","first-page":"279","volume":"31","author":"Y Shen","year":"2019","unstructured":"Shen Y, Xu J. Resveratrol Exerts Therapeutic Effects on Mice With Atopic Dermatitis. Wounds. 2019;31:279\u201384.","journal-title":"Wounds"},{"key":"1497_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177534","volume":"998","author":"W Nie","year":"2025","unstructured":"Nie W, Zhao X, Zhang Y, Zeng C, Yang H, Liu B. Chlorogenic acid alleviates DNCB-induced atopic dermatitis by inhibiting the Akt1\/NF-\u03baB signaling pathway. Eur J Pharmacol. 2025;998:177534. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177534.","journal-title":"Eur J Pharmacol"},{"key":"1497_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115368","volume":"208","author":"N Yang","year":"2023","unstructured":"Yang N, Shao H, Deng J, Yang Y, Tang Z, Wu G, et al. Dictamnine ameliorates chronic itch in DNFB-induced atopic dermatitis mice via inhibiting MrgprA3. Biochem Pharmacol. 2023;208:115368. https:\/\/doi.org\/10.1016\/j.bcp.2022.115368.","journal-title":"Biochem Pharmacol"},{"key":"1497_CR230","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1248\/bpb.b23-00436","volume":"47","author":"Y Huang","year":"2024","unstructured":"Huang Y, Zhao C, Zheng G, Yuan Y, Gong L, Liu R, et al. Dictamnine ameliorates DNFB-induced atopic dermatitis like skin lesions in mice by inhibiting M1 macrophage polarization and promoting autophagy. Biol Pharm Bull. 2024;47:175\u201386. https:\/\/doi.org\/10.1248\/bpb.b23-00436.","journal-title":"Biol Pharm Bull"},{"key":"1497_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118139","volume":"258","author":"X Chen","year":"2020","unstructured":"Chen X, Lin J, Liang Q, Chen X, Wu Z. Pseudoephedrine alleviates atopic dermatitis-like inflammatory responses in vivo and in vitro. Life Sci. 2020;258:118139. https:\/\/doi.org\/10.1016\/j.lfs.2020.118139.","journal-title":"Life Sci"},{"key":"1497_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110079","volume":"118","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhang H, Qi C, Guo H, Jiao X, Yan J, et al. Ursolic acid ameliorates DNCB-induced atopic dermatitis-like symptoms in mice by regulating TLR4\/NF-\u03baB and Nrf2\/HO-1 signaling pathways. Int Immunopharmacol. 2023;118:110079. https:\/\/doi.org\/10.1016\/j.intimp.2023.110079.","journal-title":"Int Immunopharmacol"},{"key":"1497_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154211","volume":"104","author":"Y-M Kang","year":"2022","unstructured":"Kang Y-M, Kim H-M, Lee M, An H-J. Effects of echinocystic acid on atopic dermatitis and allergic inflammation of the skin and lungs. Phytomedicine. 2022;104:154211. https:\/\/doi.org\/10.1016\/j.phymed.2022.154211.","journal-title":"Phytomedicine"},{"key":"1497_CR234","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.dmpk.2019.10.006","volume":"35","author":"T Iwatsubo","year":"2020","unstructured":"Iwatsubo T. Evaluation of drug\u2013drug interactions in drug metabolism: differences and harmonization in guidance\/guidelines. Drug Metab Pharmacokinet. 2020;35:71\u20135. https:\/\/doi.org\/10.1016\/j.dmpk.2019.10.006.","journal-title":"Drug Metab Pharmacokinet"},{"key":"1497_CR235","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/17425255.2018.1519546","volume":"14","author":"C He","year":"2018","unstructured":"He C, Wan H. Drug metabolism and metabolite safety assessment in drug discovery and development. Expert Opin Drug Metab Toxicol. 2018;14:1071\u201385. https:\/\/doi.org\/10.1080\/17425255.2018.1519546.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1497_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.153981","volume":"99","author":"CH Lee","year":"2022","unstructured":"Lee CH, Yang H, Park JHY, Kim J-E, Lee KW. Piceatannol, a metabolite of resveratrol, attenuates atopic dermatitis by targeting Janus kinase 1. Phytomedicine. 2022;99:153981. https:\/\/doi.org\/10.1016\/j.phymed.2022.153981.","journal-title":"Phytomedicine"},{"key":"1497_CR237","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.chom.2025.03.011","volume":"33","author":"M Luo","year":"2025","unstructured":"Luo M, Song X. Phyto-metabolites on guard: role of gut microbial deglycosylation. Cell Host Microbe. 2025;33:451\u20133. https:\/\/doi.org\/10.1016\/j.chom.2025.03.011.","journal-title":"Cell Host Microbe"},{"key":"1497_CR238","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.1021\/acsomega.4c11325","volume":"10","author":"M Corti","year":"2025","unstructured":"Corti M, Annunziata F, Colacicco A, Tamborini L, Molinari F, Contente ML, et al. Enzymatic deglycosylation and lipophilization of soy glycosides into value-added compounds for food and cosmetic applications. ACS Omega. 2025;10:12417\u201324. https:\/\/doi.org\/10.1021\/acsomega.4c11325.","journal-title":"ACS Omega"},{"key":"1497_CR239","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2133\/dmpk.DMPK-11-RG-160","volume":"27","author":"R-N Zhou","year":"2012","unstructured":"Zhou R-N, Song Y-L, Ruan J-Q, Wang Y-T, Yan R. Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of astragaloside IV, a marker compound of Astragali Radix, in traditional oral use of the herb. Drug Metab Pharmacokinet. 2012;27:586\u201397. https:\/\/doi.org\/10.2133\/dmpk.DMPK-11-RG-160.","journal-title":"Drug Metab Pharmacokinet"},{"key":"1497_CR240","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1039\/d1fo04362e","volume":"13","author":"CH Lee","year":"2022","unstructured":"Lee CH, Yang H, Yoon Park JH, Kim J-E, Lee KW. Orobol from enzyme biotransformation attenuates Dermatophagoides farinae-induced atopic dermatitis-like symptoms in NC\/Nga mice. Food Funct. 2022;13:4592\u20139. https:\/\/doi.org\/10.1039\/d1fo04362e.","journal-title":"Food Funct"},{"key":"1497_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2026.157987","volume":"153","author":"Y Guo","year":"2026","unstructured":"Guo Y, Xu X, Han A, Song F, Zhang Y, Jiang X, et al. Isorhamnetin alleviates diet induced MASLD in mice by modulating gut microbiota and bile acid metabolism. Phytomedicine. 2026;153:157987. https:\/\/doi.org\/10.1016\/j.phymed.2026.157987.","journal-title":"Phytomedicine"},{"key":"1497_CR242","doi-asserted-by":"publisher","first-page":"1900905","DOI":"10.1002\/mnfr.201900905","volume":"64","author":"Y Dai","year":"2020","unstructured":"Dai Y, Lim JX, Yeo SCM, Xiang X, Tan KS, Fu JH, et al. Biotransformation of piceatannol, a dietary resveratrol derivative: promises to human health. Mol Nutr Food Res. 2020;64:1900905. https:\/\/doi.org\/10.1002\/mnfr.201900905.","journal-title":"Mol Nutr Food Res"},{"key":"1497_CR243","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1652860","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Mei Y-Q, Hou L, Li K-J. Therapeutic potential of plant-derived natural products against drug-induced liver injury. Front Pharmacol. 2025;16:1652860. https:\/\/doi.org\/10.3389\/fphar.2025.1652860.","journal-title":"Front Pharmacol"},{"key":"1497_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120947","volume":"358","author":"X Li","year":"2026","unstructured":"Li X, Dong L, Cui X, Deng X, Zhai Y, Wang X, et al. Elucidation of Cortex Dictamni hepatotoxicity mechanisms through toxic component identification and integrated multi-omics analysis. J Ethnopharmacol. 2026;358:120947. https:\/\/doi.org\/10.1016\/j.jep.2025.120947.","journal-title":"J Ethnopharmacol"},{"key":"1497_CR245","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1305835","author":"F Rispo","year":"2024","unstructured":"Rispo F, De NegriAtanasio G, Demori I, Costa G, Marchese E, Perera-del-Rosario S, et al. An extensive review on phenolic compounds and their potential estrogenic properties on skin physiology. Front Cell Dev Biol. 2024. https:\/\/doi.org\/10.3389\/fcell.2023.1305835.","journal-title":"Front Cell Dev Biol"},{"key":"1497_CR246","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1393409","author":"Y Ma","year":"2024","unstructured":"Ma Y, Zhao Y, Luo M, Jiang Q, Liu S, Jia Q, et al. Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review. Front Pharmacol. 2024. https:\/\/doi.org\/10.3389\/fphar.2024.1393409.","journal-title":"Front Pharmacol"},{"key":"1497_CR247","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.sajb.2025.01.008","volume":"178","author":"R Mulaudzi","year":"2025","unstructured":"Mulaudzi R, Lebelo SL, Maqolo K, Erhabor RC, Tshabalala T, McGaw LJ, et al. Antibacterial, antioxidant, anti-inflammatory activities and skin irritation side effects of Spirostachys africana stem-bark extracts used traditionally for child skincare by isiXhosa communities in South Africa. S Afr J Bot. 2025;178:257\u201365. https:\/\/doi.org\/10.1016\/j.sajb.2025.01.008.","journal-title":"S Afr J Bot"},{"key":"1497_CR248","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673428595251209114801","author":"M Shanaida","year":"2026","unstructured":"Shanaida M, Oleshchuk O, Shevchuk O, Posokhova K, Ivankiv Y, Mocherniuk K, et al. Herbal medicines and drugs interactions: cytochrome P450 responsibility. CMC. 2026. https:\/\/doi.org\/10.2174\/0109298673428595251209114801.","journal-title":"CMC"},{"key":"1497_CR249","doi-asserted-by":"publisher","DOI":"10.1007\/s43188-026-00356-w","author":"CH Lim","year":"2026","unstructured":"Lim CH, Yu J, Jeon JS, Kim SK. In vitro study of inhibitory effects on cytochrome P450 by thirty-nine natural products with pharmacological activities. Toxicol Res. 2026. https:\/\/doi.org\/10.1007\/s43188-026-00356-w.","journal-title":"Toxicol Res"},{"key":"1497_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29235760","volume":"29","author":"A Intharuksa","year":"2024","unstructured":"Intharuksa A, Kuljarusnont S, Sasaki Y, Tungmunnithum D. Flavonoids and other polyphenols: bioactive molecules from traditional medicine recipes\/medicinal plants and their potential for phytopharmaceutical and medical application. Molecules. 2024;29:5760. https:\/\/doi.org\/10.3390\/molecules29235760.","journal-title":"Molecules"},{"key":"1497_CR251","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2004.02.013","volume":"36","author":"T Shiohara","year":"2004","unstructured":"Shiohara T, Hayakawa J, Mizukawa Y. Animal models for atopic dermatitis: are they relevant to human disease? J Dermatol Sci. 2004;36:1\u20139. https:\/\/doi.org\/10.1016\/j.jdermsci.2004.02.013.","journal-title":"J Dermatol Sci"},{"key":"1497_CR252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2014.08.002","volume":"155","author":"MT Graham","year":"2014","unstructured":"Graham MT, Nadeau KC. Lessons learned from mice and man: mimicking human allergy through mouse models. Clin Immunol. 2014;155:1\u201316. https:\/\/doi.org\/10.1016\/j.clim.2014.08.002.","journal-title":"Clin Immunol"},{"key":"1497_CR253","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s40521-020-00263-x","volume":"7","author":"P Cochez","year":"2020","unstructured":"Cochez P, Choteau M, Limaye N, Baeck M, Dumoutier L. Implication of T helper cytokines in contact dermatitis and atopic dermatitis. Curr Treat Options Allergy. 2020;7:258\u201373. https:\/\/doi.org\/10.1007\/s40521-020-00263-x.","journal-title":"Curr Treat Options Allergy"},{"key":"1497_CR254","doi-asserted-by":"publisher","first-page":"636","DOI":"10.5187\/jast.2024.e93","volume":"67","author":"J Kwak","year":"2025","unstructured":"Kwak J, Doo H, Kim ES, Keum GB, Ryu S, Choi Y, et al. A refined comparative mouse model of acute and chronic atopic dermatitis. J Anim Sci Technol. 2025;67:636\u201350. https:\/\/doi.org\/10.5187\/jast.2024.e93.","journal-title":"J Anim Sci Technol"},{"key":"1497_CR255","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/imcb.12365","volume":"98","author":"S Guerrero-Aspizua","year":"2020","unstructured":"Guerrero-Aspizua S, Carretero M, Conti CJ, Del R\u00edo M. The importance of immunity in the development of reliable animal models for psoriasis and atopic dermatitis. Immunol Cell Biol. 2020;98:626\u201338. https:\/\/doi.org\/10.1111\/imcb.12365.","journal-title":"Immunol Cell Biol"},{"key":"1497_CR256","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040613","volume":"10","author":"J Choi","year":"2021","unstructured":"Choi J, Sutaria N, Roh YS, Bordeaux Z, Alphonse MP, Kwatra SG, et al. Translational relevance of mouse models of atopic dermatitis. J Clin Microbiol. 2021;10:613. https:\/\/doi.org\/10.3390\/jcm10040613.","journal-title":"J Clin Microbiol"},{"key":"1497_CR257","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.anai.2019.03.033","volume":"123","author":"PM Brunner","year":"2019","unstructured":"Brunner PM. Early immunologic changes during the onset of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123:152\u20137. https:\/\/doi.org\/10.1016\/j.anai.2019.03.033.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1497_CR258","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/146832","volume":"2014","author":"R F\u00fcrst","year":"2014","unstructured":"F\u00fcrst R, Z\u00fcndorf I. Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress. Mediators Inflamm. 2014;2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/146832.","journal-title":"Mediators Inflamm"},{"key":"1497_CR259","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-025-00718-3","volume":"26","author":"S Qin","year":"2025","unstructured":"Qin S, Yang Z, Lei J, Xie Q, Jiang L, Fan Y, et al. Comparative efficacy of preventive vs. therapeutic resveratrol in modulating gut microbiota and alleviating inflammation in DSS-induced colitis. BMC Immunol. 2025;26:42. https:\/\/doi.org\/10.1186\/s12865-025-00718-3.","journal-title":"BMC Immunol"},{"key":"1497_CR260","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/jdv.19911","volume":"38","author":"K Pa\u017eur","year":"2024","unstructured":"Pa\u017eur K, Francuzik W, El-Mahmoud H, Kraft M, Worm M. Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti-IL-4R\u03b1 therapy. J Eur Acad Dermatol Venereol. 2024;38:1749\u201359. https:\/\/doi.org\/10.1111\/jdv.19911.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1497_CR261","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2025.0021","author":"M Steinhoff","year":"2025","unstructured":"Steinhoff M, Yosipovitch G, Canchy L, Roque Ferreira B, Aguirre CC, Tempark T, et al. Breaking the itch-scratch cycle: an integrative approach for atopic dermatitis. Dermatitis. 2025. https:\/\/doi.org\/10.1089\/derm.2025.0021.","journal-title":"Dermatitis"},{"key":"1497_CR262","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci10110659","volume":"10","author":"B Fernandes","year":"2023","unstructured":"Fernandes B, Alves S, Schmidt V, Bizarro AF, Pinto M, Pereira H, et al. Primary prevention of canine atopic dermatitis: breaking the cycle\u2014a narrative review. Vet Sci. 2023;10:659. https:\/\/doi.org\/10.3390\/vetsci10110659.","journal-title":"Vet Sci"},{"key":"1497_CR263","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00119","volume":"4","author":"E De Vuyst","year":"2017","unstructured":"De Vuyst E, Salmon M, Evrard C, Lambert De Rouvroit C, Poumay Y. Atopic dermatitis studies through in vitro models. Front Med. 2017;4:119. https:\/\/doi.org\/10.3389\/fmed.2017.00119.","journal-title":"Front Med"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01497-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:42:09Z","timestamp":1789526529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01497-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":263,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01497-8","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"219"}}